| Year |
Citation |
Score |
| 2024 |
Lulla RR, Buxton A, Krailo MD, Lazow MA, Boue DR, Leach JL, Lin T, Geller JI, Kumar SS, Nikiforova MN, Chandran U, Jogal SS, Nelson MD, Onar-Thomas A, Haas-Kogan DA, et al. Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study. Neuro-Oncology Advances. 6: vdae035. PMID 38596718 DOI: 10.1093/noajnl/vdae035 |
0.369 |
|
| 2023 |
Rich BS, Dicken BJ, Billmire DF, Weil BR, Ross J, Fallahazad N, Krailo M, Shaikh F, Frazier AL, Hazard FK, Nuño MM. Characterizing Lymphovascular Invasion in Pediatric and Adolescent Malignant Ovarian Nongerminomatous Germ Cell Tumors: A Report from the Children's Oncology Group. Journal of Pediatric Surgery. PMID 37699777 DOI: 10.1016/j.jpedsurg.2023.08.008 |
0.319 |
|
| 2023 |
Cash T, Krailo MD, Buxton AB, Pawel BR, Healey JH, Binitie O, Marcus KJ, Grier HE, Grohar PJ, Reed DR, Weiss AR, Gorlick R, Janeway KA, DuBois SG, Womer RB. Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300053. PMID 37651654 DOI: 10.1200/JCO.23.00053 |
0.37 |
|
| 2023 |
Reed DR, Grohar P, Rubin E, Binitie O, Krailo M, Davis J, DuBois SG, Janeway KA. Children's Oncology Group's 2023 blueprint for research: Bone tumors. Pediatric Blood & Cancer. e30583. PMID 37501549 DOI: 10.1002/pbc.30583 |
0.313 |
|
| 2023 |
Vieira AGS, Puthenpura V, Krailo M, Fallahazad N, Brougham MFH, Murray MJ, Frazier AL, Lopes LF, Pashankar F. Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium. Pediatric Blood & Cancer. e30426. PMID 37243320 DOI: 10.1002/pbc.30426 |
0.356 |
|
| 2023 |
Warren KE, Vezina G, Krailo M, Springer L, Buxton A, Peer CJ, Figg WD, William-Hughes C, Kessel S, Fouladi M, Gajjar A, Bowers D. Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201777. PMID 37126770 DOI: 10.1200/JCO.22.01777 |
0.332 |
|
| 2023 |
Thompson PA, Malogolowkin MH, Furman WL, Piao J, Krailo MD, Chung N, Brock L, Towbin AJ, McCarville EB, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Tiao GM, et al. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. Pediatric Blood & Cancer. e30365. PMID 37073741 DOI: 10.1002/pbc.30365 |
0.334 |
|
| 2023 |
Trobaugh-Lotrario AD, Maibach R, Aronson DC, Rangaswami A, Häberle B, O'Neill AF, Schmid I, Ansari M, Hishiki T, Ranganathan S, Alaggio R, de Krijger RR, Tanaka Y, Cho SJ, Vokuhl C, ... ... Krailo M, et al. Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC). Cancers. 15. PMID 36672416 DOI: 10.3390/cancers15020467 |
0.306 |
|
| 2023 |
DuBois SG, Krailo MD, Glade-Bender J, Buxton A, Laack N, Randall RL, Chen HX, Seibel NL, Boron M, Terezakis S, Hill-Kayser C, Hayes A, Reid JM, Teot L, Rakheja D, et al. Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201815. PMID 36669140 DOI: 10.1200/JCO.22.01815 |
0.326 |
|
| 2022 |
Singla N, Wong J, Singla S, Krailo M, Huang L, Shaikh F, Billmire D, Rescorla F, Ross J, Dicken B, Amatruda JF, Frazier AL, Bagrodia A. Response to commentary re: Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's oncology group. Journal of Pediatric Urology. PMID 35868999 DOI: 10.1016/j.jpurol.2022.06.027 |
0.355 |
|
| 2022 |
Vasudevan SA, Meyers RL, Finegold MJ, López-Terrada D, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Tiao GM, Weldon CB, Malogolowkin MH, Krailo MD, Piao J, Randazzo J, Towbin AJ, et al. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's oncology group trial, AHEP0731. Journal of Pediatric Surgery. PMID 35810020 DOI: 10.1016/j.jpedsurg.2022.05.022 |
0.315 |
|
| 2022 |
Singla N, Wong J, Singla S, Krailo M, Huang L, Shaikh F, Billmire D, Rescorla F, Ross J, Dicken B, Amatruda JF, Lindsay Frazier A, Bagrodia A. Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's Oncology Group. Journal of Pediatric Urology. PMID 35606324 DOI: 10.1016/j.jpurol.2022.04.022 |
0.353 |
|
| 2021 |
Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, Chung N, Randazzo J, Malogolowkin MH, Furman WL, McCarville EB, Towbin AJ, Tiao GM, Dunn SP, Langham MR, et al. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100803. PMID 34874751 DOI: 10.1200/JCO.21.00803 |
0.375 |
|
| 2021 |
Katzenstein HM, Malogolowkin MH, Krailo MD, Piao J, Towbin AJ, McCarville MB, Tiao GM, Dunn SP, Langham MR, McGahren ED, Finegold MJ, Ranganathan S, Weldon CB, Thompson PA, Trobaugh-Lotrario AD, et al. Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer. PMID 34762296 DOI: 10.1002/cncr.34014 |
0.366 |
|
| 2021 |
Leavey PJ, Laack NN, Krailo MD, Buxton A, Randall RL, DuBois SG, Reed DR, Grier HE, Hawkins DS, Pawel B, Nadel H, Womer RB, Letson GD, Bernstein M, Brown K, et al. Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100358. PMID 34652968 DOI: 10.1200/JCO.21.00358 |
0.344 |
|
| 2021 |
Collier AB, Krailo MD, Dang HM, DuBois SG, Hawkins DS, Bernstein ML, Bomgaars LR, Reed DR, Gorlick RG, Janeway KA. Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group. Pediatric Blood & Cancer. e29333. PMID 34496122 DOI: 10.1002/pbc.29333 |
0.366 |
|
| 2021 |
Su JM, Kilburn LB, Mansur DB, Krailo M, Buxton A, Adekunle A, Gajjar A, Adamson PC, Weigel B, Fox E, Blaney SM, Fouladi M. Phase 1/2 Trial of Vorinostat and Radiation and Maintenance Vorinostat in Children with Diffuse Intrinsic Pontine Glioma: A Children's Oncology Group Report. Neuro-Oncology. PMID 34347089 DOI: 10.1093/neuonc/noab188 |
0.314 |
|
| 2021 |
Levy AS, Krailo M, Chi S, Villaluna D, Springer L, Williams-Hughes C, Fouladi M, Gajjar A. Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial. Pediatric Blood & Cancer. e29031. PMID 33844469 DOI: 10.1002/pbc.29031 |
0.37 |
|
| 2020 |
Shaikh F, Stark D, Fonseca A, Dang H, Xia C, Krailo M, Pashankar F, Rodriguez-Galindo C, Olson TA, Nicholson JC, Murray MJ, Amatruda JF, Billmire D, Stoneham S, Frazier AL. Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium. Cancer. PMID 33079404 DOI: 10.1002/cncr.33273 |
0.305 |
|
| 2020 |
Jubran RF, Villablanca JG, Krailo M, Piao J, Huang L, Murphree AL, O'Brien J, Gombos D, Shields CL, Meadows A, Chintagumpala M. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Pediatric Blood & Cancer. e28502. PMID 32589362 DOI: 10.1002/Pbc.28502 |
0.347 |
|
| 2020 |
Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, et al. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database. Pediatric Blood & Cancer. e28350. PMID 32383794 DOI: 10.1002/Pbc.28350 |
0.398 |
|
| 2020 |
Reddy AT, Strother DR, Judkins AR, Burger PC, Pollack IF, Krailo MD, Buxton AB, Williams-Hughes C, Fouladi M, Mahajan A, Merchant TE, Ho B, Mazewski CM, Lewis VA, Gajjar A, et al. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901776. PMID 32105509 DOI: 10.1200/Jco.19.01776 |
0.441 |
|
| 2020 |
Hamid A, Funt SA, Markt SC, Bromberg M, O'Donnell D, Adra N, Taza F, Albany C, Krailo MD, Frazier AL, Einhorn LH, Feldman DR, Sweeney C. Causes and patterns of mortality in patients with lethal germ cell tumor (GCT). Journal of Clinical Oncology. 38: 421-421. DOI: 10.1200/Jco.2020.38.6_Suppl.421 |
0.363 |
|
| 2020 |
Mascarenhas L, Buxton A, DuBois SG, Wang D, Laack NN, Brown KLB, Pawel B, Nadel HR, Davis J, Hawkins DS, Grier HE, Womer RB, Stringham D, Reed DR, Janeway KA, ... ... Krailo MD, et al. Maximum tumor dimension and tumor volume as prognostic factors in patients with newly diagnosed localized Ewing sarcoma (ES)- a report from the Children’s Oncology Group (COG). Journal of Clinical Oncology. 38: 11529-11529. DOI: 10.1200/Jco.2020.38.15_Suppl.11529 |
0.375 |
|
| 2020 |
Hingorani P, Krailo MD, Buxton A, Hutson PR, Davis J, Janeway KA, Gorlick RG, Isakoff M. Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421): A report from the Children’s Oncology Group. Journal of Clinical Oncology. 38: 10508-10508. DOI: 10.1200/Jco.2020.38.15_Suppl.10508 |
0.392 |
|
| 2019 |
Kopp LM, Womer RB, Schwartz CL, Ebb DH, Franco VI, Hall D, Barkauskas DA, Krailo MD, Grier HE, Meyers PA, Wexler LH, Marina NM, Janeway KA, Gorlick R, Bernstein ML, et al. Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group. Cardio-Oncology (London, England). 5: 15. PMID 32154021 DOI: 10.1186/s40959-019-0050-9 |
0.34 |
|
| 2019 |
Kopp LM, Malempati S, Krailo M, Gao Y, Buxton A, Weigel BJ, Hawthorne T, Crowley E, Moscow JA, Reid JM, Villalobos V, Randall RL, Gorlick R, Janeway KA. Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group. European Journal of Cancer (Oxford, England : 1990). 121: 177-183. PMID 31586757 DOI: 10.1016/J.Ejca.2019.08.015 |
0.393 |
|
| 2019 |
Ji L, McShane LM, Krailo M, Sposto R. Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial. Clinical Trials (London, England). 1740774519875969. PMID 31581815 DOI: 10.1177/1740774519875969 |
0.3 |
|
| 2019 |
Calaminus G, Jenney M, Hjorth L, Baust K, Bernstein M, Bielack S, Vos P, Hogendoorn PCW, Jovic G, Krailo M, Kreitz K, Marina N, Popoola BO, Sauerland C, Smeland S, et al. Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy. Jmir Research Protocols. 8: e14406. PMID 31573951 DOI: 10.2196/14406 |
0.301 |
|
| 2019 |
Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, Bhadri V, Brichard B, Claude L, Craft A, Amler S, Gaspar N, Gelderblom H, Goldsby R, Gorlick R, Grier HE, ... ... Krailo M, et al. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900915. PMID 31553693 DOI: 10.1200/Jco.19.00915 |
0.361 |
|
| 2019 |
Rodriguez-Galindo C, Krailo MD, Krasin MJ, Huang L, McCarville MB, Hicks J, Pashankar F, Pappo AS. Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901276. PMID 31553639 DOI: 10.1200/Jco.19.01276 |
0.402 |
|
| 2019 |
Chévez-Barrios P, Eagle RC, Krailo M, Piao J, Albert DM, Gao Y, Vemuganti G, Ali MJ, Khetan V, Honavar SG, O'Brien J, Leahey AM, Matthay K, Meadows A, Chintagumpala M. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801808. PMID 31539297 DOI: 10.1200/Jco.18.01808 |
0.408 |
|
| 2019 |
O'Neill AF, Xia C, Krailo MD, Shaikh F, Pashankar FD, Billmire DF, Olson TA, Amatruda JF, Villaluna D, Huang L, Malogolowkin M, Rodriguez-Galindo C, Frazier AL. α-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium. Cancer. PMID 31355926 DOI: 10.1002/Cncr.32363 |
0.447 |
|
| 2019 |
Depani S, Stoneham S, Krailo M, Xia C, Nicholson J. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII). European Journal of Cancer (Oxford, England : 1990). 118: 49-57. PMID 31306943 DOI: 10.1016/J.Ejca.2019.05.001 |
0.448 |
|
| 2019 |
Weldon CB, Madenci AL, Tiao GM, Dunn SP, Langham MR, McGahren ED, Ranganathan S, López-Terrada DH, Finegold MJ, Malogolowkin MH, Piao J, Huang L, Krailo MD, Meyers RL, Katzenstein HM. Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the Children's Oncology Group AHEP 0731 Liver Tumor Committee. Journal of Pediatric Surgery. PMID 31126688 DOI: 10.1016/J.Jpedsurg.2019.05.004 |
0.378 |
|
| 2019 |
Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, Finegold MJ, Ranganathan S, Dunn S, McGahren ED, Tiao GM, O'Neill AF, Qayed M, Furman WL, Xia C, et al. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial. The Lancet. Oncology. PMID 30975630 DOI: 10.1016/S1470-2045(18)30895-7 |
0.459 |
|
| 2019 |
Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, ... ... Krailo MD, et al. Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. British Journal of Cancer. PMID 30880335 DOI: 10.1038/S41416-019-0424-7 |
0.338 |
|
| 2019 |
Mosse YP, Fox E, Teachey DT, Reid JM, Sagfren SL, Carol H, Lock RB, Houghton PJ, Smith MA, Hall DC, Barkauskas DA, Krailo M, Voss SD, Berg SL, Blaney S, et al. A Phase 2 Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase 1 and Pilot Consortium ADVL0921). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30777875 DOI: 10.1158/1078-0432.Ccr-18-2675 |
0.442 |
|
| 2019 |
Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, et al. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. European Journal of Cancer (Oxford, England : 1990). 109: 36-50. PMID 30685685 DOI: 10.1016/J.Ejca.2018.11.027 |
0.414 |
|
| 2019 |
Singla S, Wong J, Singla N, Krailo M, Huang L, Shaikh F, Billmire D, Rescorla F, Ross J, Dicken B, Amatruda J, Lindsay Frazier A, Bagrodia A. Clinicopathologic predictors of outcomes in children with stage I germ cell tumours: A pooled post hoc analysis of trials from the Children’s Oncology Group European Urology Supplements. 18: 17-18. DOI: 10.1200/Jco.2020.38.6_Suppl.418 |
0.405 |
|
| 2019 |
Venkatramani R, Piao J, Krailo MD, Rodriguez-Galindo C, Pashankar FD. Carcinomas in the children and young adults: A report form Children’s Oncology Group APEC14B1 study. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E21505 |
0.356 |
|
| 2019 |
O'Neill AF, Xia C, Krailo MD, Shaikh F, Pashankar FD, Billmire DF, Olson TA, Amatruda JF, Villaluna D, Malogolowkin MH, Rodriguez-Galindo C, Frazier AL. Alfa-feto protein (AFP) as a predictor of outcome for children with germ cell tumors: A report from the malignant germ cell international consortium. Journal of Clinical Oncology. 37: 10036-10036. DOI: 10.1200/Jco.2019.37.15_Suppl.10036 |
0.417 |
|
| 2019 |
Fonseca A, Villaluna D, Krailo MD, Frazier AL, Shaikh F. Outcome of children with malignant germ cell tumors by response status at the end of induction chemotherapy. Journal of Clinical Oncology. 37: 10023-10023. DOI: 10.1200/Jco.2019.37.15_Suppl.10023 |
0.426 |
|
| 2019 |
Shaikh F, Stark DP, Dang H, Xia C, Krailo MD, Stenning SP, Pashankar FD, Rodriguez-Galindo C, Olson TA, Hale J, Depani S, Stoneham S, Nicholson J, Murray M, Amatruda JF, et al. Outcomes of adolescent males with extracranial malignant germ cell tumors compared with children and young adults: A report from the Malignant Germ Cell Tumors International Consortium (MaGIC) group. Journal of Clinical Oncology. 37: 10022-10022. DOI: 10.1200/Jco.2019.37.15_Suppl.10022 |
0.425 |
|
| 2019 |
O’Neill AF, Xia C, Krailo MD, Shaikh F, Mrcp FDPM, Billmire DF, Olson TA, Amatruda JF, Ms DV, Huang L, Malogolowkin M, Rodriguez-Galindo C, Frazier AL. Alpha-fetoprotein (AFP) as a predictor of outcome for children with germ cell tumours: A report from the Malignant Germ Cell International Consortium (MaGIC) European Urology Supplements. 18: 19. DOI: 10.1016/S1569-9056(19)32507-2 |
0.337 |
|
| 2019 |
Fonseca A, Villaluna D, Krailo M, Frazier AL, Shaikh F. Outcome of children with malignant germ cell tumours by response status at the end of induction chemotherapy European Urology Supplements. 18: 19. DOI: 10.1016/S1569-9056(19)32506-0 |
0.403 |
|
| 2019 |
Shaikh F, Stark D, Dang H, Xia C, Krailo M, Stenning S, Pashankar F, Rodriguez-Galindo C, Olson T, Depani S, Stoneham S, Nicholson J, Murray M, Amatruda J, Billmire D, et al. Outcomes of adolescent males with extracranial metastatic germ cell tumours compared with children and young adults: A report from the Malignant Germ Cell Tumour International Consortium (MaGIC) group European Urology Supplements. 18: 9. DOI: 10.1016/S1569-9056(19)32477-7 |
0.364 |
|
| 2018 |
Fonseca A, Xia C, Lorenzo AJ, Krailo M, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Billmire DF, Rodriguez-Galindo C, Frazier AL, Shaikh F. Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800790. PMID 30576269 DOI: 10.1200/Jco.18.00790 |
0.428 |
|
| 2018 |
Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Hingorani P, Collier A, Morris CD, Kolb EA, Doski JJ, Womer RB, Gorlick R, Janeway KA. A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group. Pediatric Blood & Cancer. e27524. PMID 30378256 DOI: 10.1002/Pbc.27524 |
0.441 |
|
| 2018 |
Williams LA, Pankratz N, Lane J, Krailo M, Roesler M, Richardson M, Lindsay Frazier A, Amatruda JF, Poynter JN. Klinefelter syndrome in males with germ cell tumors: A report from the children's oncology group. Cancer. PMID 30291793 DOI: 10.1002/Cncr.31667 |
0.358 |
|
| 2018 |
Spraker-Perlman HL, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Doski J, Gorlick R, Janeway KA, Isakoff MS. Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group. Pediatric Blood & Cancer. e27444. PMID 30255612 DOI: 10.1002/Pbc.27444 |
0.412 |
|
| 2018 |
Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, ... ... Krailo MD, et al. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. British Journal of Cancer. PMID 30131550 DOI: 10.1038/S41416-018-0212-9 |
0.363 |
|
| 2018 |
Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF, Brady WE, Covens A, Gershenson DM, Hale JP, Hurteau J, Murray MJ, Nicholson JC, Olson TA, Pashankar F, et al. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults? Gynecologic Oncology. PMID 29884437 DOI: 10.1016/J.Ygyno.2018.05.025 |
0.443 |
|
| 2018 |
Frazier AL, Stoneham S, Rodriguez-Galindo C, Dang H, Xia C, Olson TA, Murray MJ, Amatruda JF, Shaikh F, Pashankar F, Billmire D, Krailo M, Stark D, Brougham MFH, Nicholson JC, et al. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium. European Journal of Cancer (Oxford, England : 1990). 98: 30-37. PMID 29859339 DOI: 10.1016/J.Ejca.2018.03.004 |
0.461 |
|
| 2018 |
Minasian LM, Frazier AL, Sung L, O'Mara A, Kelaghan J, Chang KW, Krailo M, Pollock BH, Reaman G, Freyer DR. Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials. Cancer Medicine. PMID 29846043 DOI: 10.1002/Cam4.1563 |
0.389 |
|
| 2018 |
Pashankar F, Frazier AL, Krailo M, Xia C, Pappo AS, Malogolowkin M, Olson TA, Rodriguez-Galindo C. Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study. Pediatric Blood & Cancer. e27111. PMID 29697191 DOI: 10.1002/Pbc.27111 |
0.493 |
|
| 2018 |
Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, et al. Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors. The Oncologist. 23: 272. PMID 29449513 DOI: 10.1634/Theoncologist.2014-0009Erratum |
0.322 |
|
| 2018 |
Faure Conter C, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F, Krailo M, Billmire D, Patte C, Fresneau B, Shaikh F, Stoneham S, Nicholson J, Murray M, Frazier AL. Ovarian Yolk Sac Tumors; Does Age Matter? International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 28: 77-84. PMID 29194189 DOI: 10.1097/Igc.0000000000001149 |
0.335 |
|
| 2018 |
Marcotte E, Spector LG, Nelson H, Tomlinson G, Krailo M, Mills L, Poynter J. Abstract 5336: Methylation patterns in hepatoblastoma: A report from the Children's Oncology Group Cancer Research. 78: 5336-5336. DOI: 10.1158/1538-7445.Am2018-5336 |
0.421 |
|
| 2017 |
Dicken BJ, Billmire DF, Krailo M, Xia C, Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Rescorla FJ, Egler RA, Ross JH, Rodriguez-Galindo C, Frazier AL. Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study. Pediatric Blood & Cancer. PMID 29286555 DOI: 10.1002/Pbc.26913 |
0.459 |
|
| 2017 |
Poynter JN, Richardson M, Roesler M, Krailo M, Amatruda JF, Frazier AL. Family history of cancer in children and adolescents with germ cell tumours: a report from the Children's Oncology Group. British Journal of Cancer. PMID 29065103 DOI: 10.1038/Bjc.2017.358 |
0.346 |
|
| 2017 |
Ahmed SK, Randall RL, DuBois SG, Harmsen WS, Krailo M, Marcus KJ, Janeway KA, Geller DS, Sorger JI, Womer RB, Granowetter L, Grier HE, Gorlick RG, Laack NNI. Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group. International Journal of Radiation Oncology, Biology, Physics. PMID 28964585 DOI: 10.1016/J.Ijrobp.2017.08.020 |
0.415 |
|
| 2017 |
O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, et al. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017735654. PMID 28892430 DOI: 10.1200/Jco.2017.73.5654 |
0.484 |
|
| 2017 |
Flores RJ, Kelly AJ, Li Y, Chen X, McGee C, Krailo M, Barkauskas DA, Hicks J, Man TK. The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma. Pediatric Blood & Cancer. PMID 28544777 DOI: 10.1002/Pbc.26659 |
0.327 |
|
| 2017 |
Davis LE, Janeway KA, Weiss AR, Chen YE, Scharschmidt TJ, Krailo M, Bender JLG, Kopp LM, Patel SR, Schwartz GK, Horvath LE, Hawkins DS, Chuk MK, Reinke DK, Gorlick RG, et al. Clinical trial enrollment of adolescents and young adults with sarcoma. Cancer. PMID 28493547 DOI: 10.1002/Cncr.30757 |
0.329 |
|
| 2017 |
Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Villaluna D, Krailo M, Billmire DF, Rescorla FJ, Egler RA, Dicken BJ, Ross JH, Schlatter M, Rodriguez-Galindo C, et al. Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016676544. PMID 28240974 DOI: 10.1200/Jco.2016.67.6544 |
0.458 |
|
| 2017 |
Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, Tiao GM, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Rodriguez-Galindo C, Meyers RL. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee. Cancer. PMID 28211941 DOI: 10.1002/Cncr.30591 |
0.418 |
|
| 2017 |
Dunkel IJ, Krailo MD, Chantada GL, Banerjee A, Abouelnaga S, Buchsbaum J, Merchant TE, Granger M, Jubran RF, Kellick M, Weinstein J, Abramson DH, Rodriguez-Galindo C, Chintagumpala MM. Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children's Oncology Group (COG) trial (ARET0321). Journal of Clinical Oncology. 35: 10506-10506. DOI: 10.1200/Jco.2017.35.15_Suppl.10506 |
0.398 |
|
| 2017 |
Levy A, Krailo M, Chi S, Williams-Hughes C, Bancroft M, Villaluna D, Fouladi M, Gajjar A. PDCT-09. TEMOZOLOMIDE WITH IRINOTECAN VERSUS TEMOZOLOMIDE, IRINOTECAN PLUS BEVACIZUMAB FOR RECURRENT MEDULLOBLASTOMA/CNS PNET OF CHILDHOOD: REPORT OF A COG RANDOMIZED PHASE II SCREENING TRIAL Neuro-Oncology. 19: vi186-vi186. DOI: 10.1093/Neuonc/Nox168.753 |
0.322 |
|
| 2017 |
Ahmed SK, Harmsen WS, Dubois SG, Krailo M, Marcus KJ, Janeway KA, Geller DS, Sorger JI, Womer RB, Granowetter L, Grier HE, Randall RL, Gorlick RG, Laack NN. Local Control in Ewing Sarcoma: Results of 956 patients treated on the INT-0091, INT-0154, and AEWS0031 Trials International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.079 |
0.335 |
|
| 2016 |
Friedman DL, Krailo M, Villaluna D, Gombos D, Langholz B, Jubran R, Shields C, Murphree L, O'Brien J, Kessel S, Rodriguez-Galindo C, Chintagumpala M, Meadows AT. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group. Pediatric Blood & Cancer. PMID 28019092 DOI: 10.1002/Pbc.26394 |
0.38 |
|
| 2016 |
Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D, VanSoelen ML, Wiernikowski J, Neuwelt EA, Sung L. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial. The Lancet. Oncology. PMID 27914822 DOI: 10.1016/S1470-2045(16)30625-8 |
0.353 |
|
| 2016 |
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. The Lancet. Oncology. PMID 27884679 DOI: 10.1016/S1470-2045(16)30598-8 |
0.437 |
|
| 2016 |
Treister N, Nieder M, Baggott C, Olson E, Chen L, Dang H, Krailo M, August A, Sung L. Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation. British Journal of Cancer. PMID 27875526 DOI: 10.1038/Bjc.2016.380 |
0.313 |
|
| 2016 |
Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KL, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, et al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. The Lancet. Oncology. PMID 27569442 DOI: 10.1016/S1470-2045(16)30214-5 |
0.396 |
|
| 2016 |
Flores RJ, Kelly AJ, Li Y, Nakka M, Barkauskas DA, Krailo M, Wang LL, Perlaky L, Lau CC, Hicks MJ, Man TK. A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG. Cancer. PMID 27529817 DOI: 10.1002/Cncr.30272 |
0.341 |
|
| 2016 |
Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin AM, Grier HE, Weigel B, Blaney SM, Gorlick R, Janeway KA. Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27400942 DOI: 10.1200/Jco.2015.65.5381 |
0.461 |
|
| 2016 |
Cash T, McIlvaine E, Krailo MD, Lessnick SL, Lawlor ER, Laack N, Sorger J, Marina N, Grier HE, Granowetter L, Womer RB, DuBois SG. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group. Pediatric Blood & Cancer. PMID 27297500 DOI: 10.1002/Pbc.26096 |
0.399 |
|
| 2016 |
Green AL, Chintagumpala M, Krailo M, Langholz B, Albert D, Eagle R, Cockburn M, Chevez-Barrios P, Rodriguez-Galindo C. Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study. Ophthalmology. PMID 27262763 DOI: 10.1016/J.Ophtha.2016.04.043 |
0.334 |
|
| 2016 |
Frazier AL, Krailo M, Poynter J. Can Big Data Shed Light on the Origins of Pediatric Cancer? Pediatrics. PMID 27217479 DOI: 10.1542/Peds.2016-0983 |
0.308 |
|
| 2016 |
Daw NC, Laack NN, McIlvaine EJ, Krailo M, Womer RB, Granowetter L, Grier HE, Marina NM, Bernstein ML, Gebhardt MC, Marcus KJ, Advani SM, Healey JH, Letson GD, Gorlick RG, et al. Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group. Annals of Surgical Oncology. PMID 27216741 DOI: 10.1245/S10434-016-5269-1 |
0.405 |
|
| 2016 |
Li Y, Nakka M, Kelly AJ, Lau CC, Krailo M, Barkauskas DA, Hicks JM, Man TK. p27 is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma. Cancer Research. PMID 27197201 DOI: 10.1158/0008-5472.Can-15-3189 |
0.328 |
|
| 2016 |
Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. Pediatric Blood & Cancer. PMID 27128693 DOI: 10.1002/Pbc.26034 |
0.451 |
|
| 2016 |
Jakacki RI, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum MK, Brat DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IF. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro-Oncology. PMID 27006176 DOI: 10.1093/Neuonc/Now038 |
0.46 |
|
| 2016 |
Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo M, Barkauskas DA, Matthay KK, Womer RB, Gorlick R, Lessnick SL, et al. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26861456 DOI: 10.1158/1078-0432.Ccr-15-2516 |
0.34 |
|
| 2016 |
Morris CD, Teot LA, Bernstein ML, Marina N, Krailo MD, Villaluna D, Janeway KA, DuBois SG, Gorlick RG, Randall RL. Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group. Journal of Surgical Oncology. PMID 26776342 DOI: 10.1002/Jso.24145 |
0.393 |
|
| 2016 |
Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. 63: 54-61. PMID 26398490 DOI: 10.1002/Pbc.25753 |
0.449 |
|
| 2016 |
Dirksen U, Deley ML, Brennan B, Judson IR, Bernstein ML, Gorlick RG, Marina N, Womer RB, Cozic N, Gaspar N, Teuff GL, Marec-Berard P, Faldum A, Paulussen M, Juergens H, ... ... Krailo MD, et al. Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) compared to conventional chemotherapy combined with lung irradiation in ewing sarcoma (ES) with primary lung metastases: Results of EURO-EWING 99-R2pulm randomized trial (EE99R2pul). Journal of Clinical Oncology. 34: 11001-11001. DOI: 10.1200/Jco.2016.34.15_Suppl.11001 |
0.346 |
|
| 2016 |
Katzenstein HM, Furman WL, Malogolowkin M, Krailo MD, McCarville MB, Towbin A, Tiao G, Finegold M, Ranganathan S, Dunn S, Langham M, McGahren E, Rodriguez-Galindo C, Meyers R. Vincristine/irinotecan upfront window treatment of high-risk hepatoblastoma: A report from the Children’s Oncology Group (COG) AHEP0731 study committee. Journal of Clinical Oncology. 34: 10516-10516. DOI: 10.1200/Jco.2016.34.15_Suppl.10516 |
0.315 |
|
| 2016 |
Rodriguez-Galindo C, Pappo AS, Krailo MD, Pashankar F, Monteiro Caran EM, Hicks J, McCarville MB, Weldon CB, Malkin D, Zambetti G, Filho ACdO, LaQuaglia MP, Mastellaro MJ, Ribeiro RC. Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children’s Oncology Group ARAR0332 protocol. Journal of Clinical Oncology. 34: 10515-10515. DOI: 10.1200/Jco.2016.34.15_Suppl.10515 |
0.369 |
|
| 2016 |
Rodriguez-Galindo C, Krailo MD, Krasin MJ, McCarville MB, Hicks J, Pashankar F, Pappo AS. Treatment of childhood nasopharyngeal carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): Results of the Childrens Oncology Group ARAR0331 study. Journal of Clinical Oncology. 34: 10513-10513. DOI: 10.1200/Jco.2016.34.15_Suppl.10513 |
0.426 |
|
| 2016 |
Spector L, Lock I, Lane J, Sarver A, Krailo M, Nagarajan R, Pankratz N. Abstract A37: De novo and transmitted germline TP53 variation in pediatric osteosarcoma: A report from the Children's Oncology Group Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-A37 |
0.4 |
|
| 2016 |
Marcotte EL, Pankratz N, Amatruda J, Frazier AL, Krailo M, Davies S, Starr J, Langer E, Hallstrom C, Hooten A, Poynter JN. Abstract LB-374: Variants in BAK1 and SPRY4 are associated with pediatric germ cell tumors Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-374 |
0.332 |
|
| 2016 |
Nakka M, Li Y, Kelly AJ, Lau CC, Krailo M, Barkauskas DA, Hicks J, Man T. Abstract 2445: Cytoplasmic mislocalization of p27 promotes metastasis and its autoantibody correlates with prognosis in osteosarcoma Cancer Research. 76: 2445-2445. DOI: 10.1158/1538-7445.Am2016-2445 |
0.346 |
|
| 2016 |
Reddy A, Strother D, Judkins A, Krailo M, Gao Y, Douglas J, Mahajan A, Lewis V, Mazewski C, Laningham F, Pollack I, Gajjar A, Biegel J. AT-09TREATMENT OF ATYPICAL TERATOID RHABDOID TUMORS (ATRT) OF THE CENTRAL NERVOUS SYSTEM WITH SURGERY, INTENSIVE CHEMOTHERAPY, AND 3-D CONFORMAL RADIATION (ACNS0333). A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP Neuro-Oncology. 18: iii2.4-iii2. DOI: 10.1093/Neuonc/Now065.08 |
0.413 |
|
| 2015 |
Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng Y, Aronson D, Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, et al. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. European Journal of Cancer (Oxford, England : 1990). 52: 92-101. PMID 26655560 DOI: 10.1016/J.Ejca.2015.09.023 |
0.406 |
|
| 2015 |
Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. PMID 26579879 DOI: 10.1002/Pbc.25837 |
0.435 |
|
| 2015 |
Marina N, Granowetter L, Grier HE, Womer RB, Randall RL, Marcus KJ, McIlvaine E, Krailo M. Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report. Sarcoma. 2015: 927123. PMID 26508901 DOI: 10.1155/2015/927123 |
0.441 |
|
| 2015 |
Pashankar F, Hale JP, Dang H, Krailo M, Brady WE, Rodriguez-Galindo C, Nicholson JC, Murray MJ, Bilmire DF, Stoneham S, Arul GS, Olson TA, Stark D, Shaikh F, Amatruda JF, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. PMID 26485622 DOI: 10.1002/Cncr.29732 |
0.444 |
|
| 2015 |
Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Gorlick R, Doski JJ, Womer RB, Janeway KA. Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. PMID 26376351 DOI: 10.1002/Pbc.25754 |
0.411 |
|
| 2015 |
Pappo AS, Furman WL, Schultz KA, Ferrari A, Helman L, Krailo MD. Rare Tumors in Children: Progress Through Collaboration. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 3047-54. PMID 26304909 DOI: 10.1200/Jco.2014.59.3632 |
0.417 |
|
| 2015 |
Olson TA, Murray MJ, Rodriguez-Galindo C, Nicholson JC, Billmire DF, Krailo MD, Dang HM, Amatruda JF, Thornton CM, Arul GS, Stoneham SJ, Pashankar F, Stark D, Shaikh F, Gershenson DM, et al. Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 3018-28. PMID 26304902 DOI: 10.1200/Jco.2014.60.5337 |
0.439 |
|
| 2015 |
Meany HJ, Seibel NL, Krailo M, Villaluna D, Chen Z, Gaynon P, Neglia JP, Park JR, Hutchinson R, Sato JK, Wells RJ, Woods WG, Reaman G. Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group. Journal of Immunotherapy (Hagerstown, Md. : 1997). 38: 299-305. PMID 26261894 DOI: 10.1097/Cji.0000000000000088 |
0.339 |
|
| 2015 |
Karski EE, McIlvaine E, Segal MR, Krailo M, Grier HE, Granowetter L, Womer RB, Meyers PA, Felgenhauer J, Marina N, DuBois SG. Identification of discrete prognostic groups in Ewing sarcoma. Pediatric Blood & Cancer. PMID 26257296 DOI: 10.1002/Pbc.25709 |
0.392 |
|
| 2015 |
Kim A, Widemann BC, Krailo M, Jayaprakash N, Fox E, Weigel B, Blaney SM. Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 62: 1562-6. PMID 26207356 DOI: 10.1002/Pbc.25548 |
0.425 |
|
| 2015 |
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, et al. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26033801 DOI: 10.1200/Jco.2014.60.0734 |
0.386 |
|
| 2015 |
Chintagumpala M, Eckel SP, Krailo M, Morris M, Adesina A, Packer R, Lau C, Gajjar A. A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†. Neuro-Oncology. 17: 1132-8. PMID 25854526 DOI: 10.1093/Neuonc/Nov057 |
0.463 |
|
| 2015 |
Rescorla FJ, Ross JH, Billmire DF, Dicken BJ, Villaluna D, Davis MM, Krailo M, Cullen JW, Olson TA, Egler RA, Amatruda JF, Rodrigues-Galindo C, Frazier AL. Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology Group. Journal of Pediatric Surgery. 50: 1000-3. PMID 25812445 DOI: 10.1016/J.Jpedsurg.2015.03.026 |
0.412 |
|
| 2015 |
Glover J, Krailo M, Tello T, Marina N, Janeway K, Barkauskas D, Fan TM, Gorlick R, Khanna C. A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW Foundation. Pediatric Blood & Cancer. 62: 450-5. PMID 25611047 DOI: 10.1002/Pbc.25346 |
0.469 |
|
| 2015 |
Lerman DM, Monument MJ, McIlvaine E, Liu XQ, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB, Bridge JA, Krailo MD, Randall RL, Lessnick SL. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 62: 759-65. PMID 25464386 DOI: 10.1002/Pbc.25340 |
0.472 |
|
| 2015 |
Frazier AL, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray MJ, Amatruda JF, Thornton C, Arul GS, Billmire D, Shaikh F, Pashankar F, Stoneham S, Krailo M, Nicholson JC. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 195-201. PMID 25452439 DOI: 10.1200/Jco.2014.58.3369 |
0.472 |
|
| 2015 |
Wagner LM, Fouladi M, Ahmed A, Krailo MD, Weigel B, DuBois SG, Doyle LA, Chen H, Blaney SM. Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 62: 440-4. PMID 25446280 DOI: 10.1002/Pbc.25334 |
0.393 |
|
| 2015 |
Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, et al. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 407-14. PMID 25421877 DOI: 10.1093/Annonc/Mdu526 |
0.355 |
|
| 2015 |
Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival. Cancer. 121: 697-707. PMID 25387699 DOI: 10.1002/Cncr.29090 |
0.306 |
|
| 2015 |
DuBois SG, Krailo MD, Gebhardt MC, Donaldson SS, Marcus KJ, Dormans J, Shamberger RC, Sailer S, Nicholas RW, Healey JH, Tarbell NJ, Randall RL, Devidas M, Meyer JS, Granowetter L, et al. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer. 121: 467-75. PMID 25251206 DOI: 10.1002/Cncr.29065 |
0.359 |
|
| 2015 |
Smeland S, Whelan J, Bielack SS, Marina N, Jovic G, Butterfass-Bahloul T, Calaminus G, Eriksson M, Gelderblom H, Gorlick RG, Hogendoorn PCW, Hook J, Kager L, Krailo MD, Kühne T, et al. Event-free survival and overall survival in 2,253 patients with osteosarcoma registered to EURAMOS-1 Journal of Clinical Oncology. 33: 10512-10512. DOI: 10.1200/Jco.2015.33.15_Suppl.10512 |
0.387 |
|
| 2015 |
Cash T, McIlvaine E, Krailo MD, Lessnick SL, Lawlor ER, Laack NN, Sorger J, Marina N, Grier HE, Granowetter L, Womer RB, DuBois SG. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children’s Oncology Group. Journal of Clinical Oncology. 33: 10051-10051. DOI: 10.1200/Jco.2015.33.15_Suppl.10051 |
0.414 |
|
| 2015 |
Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin A, Grier HE, Weigel B, Blaney S, Gorlick RG, Janeway KA. Outcome of recurrent osteosarcoma patients enrolled in seven phase II trials through CCG, POG, and COG: Learning from the past to move forward. Journal of Clinical Oncology. 33: 10042-10042. DOI: 10.1200/Jco.2015.33.15_Suppl.10042 |
0.426 |
|
| 2015 |
Hoffman LM, Geller J, Leach J, Boue D, Drissi R, Chen L, Krailo M, Panandiker AP, Chow L, Haas-Kogan D, Jogal S, Nelson M, Jakacki R, Kieran M, Cohen K, et al. Tr-14A Feasibility And Randomized Phase Ii Study Of Vorinostat, Bevacizumab, Or Temozolomide During Radiation Followed By Maintenance Chemotherapy In Newly-Diagnosed Pediatric High-Grade Glioma: Children'S Oncology Group Study Acns0822 Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov061.159 |
0.431 |
|
| 2014 |
Billmire DF, Rescorla FJ, Ross JH, Schlatter MG, Dicken BJ, Krailo MD, Rodriguez-Galindo C, Olson TA, Cullen JW, Frazier AL. Impact of central surgical review in a study of malignant germ cell tumors. Journal of Pediatric Surgery. PMID 25783295 DOI: 10.1016/J.Jpedsurg.2014.12.008 |
0.352 |
|
| 2014 |
Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnick SL. Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group. Plos One. 9: e104378. PMID 25093581 DOI: 10.1371/Journal.Pone.0104378 |
0.313 |
|
| 2014 |
Turcotte LM, Georgieff MK, Ross JA, Feusner JH, Tomlinson GE, Malogolowkin MH, Krailo MD, Miller N, Fonstad R, Spector LG. Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 61: 2018-23. PMID 25044669 DOI: 10.1002/Pbc.25128 |
0.337 |
|
| 2014 |
Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, et al. Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors. The Oncologist. 19: 689-92. PMID 24899644 DOI: 10.1634/Theoncologist.2014-0009 |
0.351 |
|
| 2014 |
Musselman JR, Spector LG, Krailo MD, Reaman GH, Linabery AM, Poynter JN, Stork SK, Adamson PC, Ross JA. The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States. Cancer. 120: 3007-15. PMID 24889136 DOI: 10.1002/Cncr.28813 |
0.385 |
|
| 2014 |
Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, ... ... Krailo M, et al. Toward a drug development path that targets metastatic progression in osteosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4200-9. PMID 24803583 DOI: 10.1158/1078-0432.Ccr-13-2574 |
0.315 |
|
| 2014 |
Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N. HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatric Blood & Cancer. 61: 1558-64. PMID 24753182 DOI: 10.1002/Pbc.25074 |
0.408 |
|
| 2014 |
Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH, Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C, Frazier AL. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 465-70. PMID 24395845 DOI: 10.1200/Jco.2013.51.1006 |
0.479 |
|
| 2014 |
Altaf S, Enders F, Krailo M, Barkauskas D, Meyers P, Arndt C. Response to "High BMI at diagnosis is associated with inferior survival in patients with osteosarcoma". Pediatric Blood & Cancer. 61: 951-951. PMID 24127421 DOI: 10.1002/Pbc.24816 |
0.322 |
|
| 2014 |
Weigel B, Malempati S, Reid JM, Voss SD, Cho SY, Chen HX, Krailo M, Villaluna D, Adamson PC, Blaney SM. Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 61: 452-6. PMID 23956055 DOI: 10.1002/Pbc.24605 |
0.438 |
|
| 2014 |
Shaikh F, Dang H, Krailo MD, Hale J, Nicholson J, Rodriguez-Galindo C, Olson TA, Murray M, Amatruda J, Thornton C, Arul S, Billmire D, Frazier AL. Postrecurrence survival for pediatric extracranial malignant germ cell tumors: A report from the Malignant Germ Cell Tumors International Collaborative (MaGIC) Group. Journal of Clinical Oncology. 32: 10074-10074. DOI: 10.1200/Jco.2014.32.15_Suppl.10074 |
0.505 |
|
| 2014 |
Wagner LM, Fouladi M, Ahmed A, Krailo MD, Weigel B, DuBois SG, Doyle A, Chen HX, Blaney S. Phase II trial of cixutumumab in combination with temsirolimus in pediatric patients with recurrent or refractory sarcoma: A report from the Children’s Oncology Group. Journal of Clinical Oncology. 32: 10066-10066. DOI: 10.1200/Jco.2014.32.15_Suppl.10066 |
0.409 |
|
| 2014 |
London WB, Bagatell R, Weigel B, Fox E, Van Ryn C, Naranjo A, Krailo MD, Ahern CH, Park JR. Historical gold standard for time-to-progression (TTP) and progression-free survival (PFS) from relapsed/refractory neuroblastoma modern era (2002-2014) patients. Journal of Clinical Oncology. 32: 10034-10034. DOI: 10.1200/Jco.2014.32.15_Suppl.10034 |
0.378 |
|
| 2014 |
Volchenboum SL, Andrade J, Barkauskas DA, Krailo M, Sposto R, Ranft A, Potratz J, Dirksen U, Triche TJ, Lawlor E. Abstract A72: Do prognostic gene signatures exist in Ewing sarcoma? A report from the Children's Oncology Group Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A72 |
0.413 |
|
| 2013 |
Smeland S, Whelan J, Marina N, Hook J, Jovic G, Krailo MD, Butterfass-Bahloul T, Kühne T, Eriksson M, Teot LA, Gelderblom H, Kager L, Sundby Hall K, Gorlick RG, Randall RL, et al. MAP plus maintenance pegylated interferon α-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 "good response" randomization. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: LBA10504. PMID 28136078 DOI: 10.1200/Jco.2013.31.18_Suppl.Lba10504 |
0.363 |
|
| 2013 |
Altaf S, Enders F, Jeavons E, Krailo M, Barkauskas DA, Meyers P, Arndt C. High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 60: 2042-6. PMID 23955975 DOI: 10.1002/Pbc.24580 |
0.391 |
|
| 2013 |
Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, Häberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo M, Feusner JH. Outcomes for patients with congenital hepatoblastoma. Pediatric Blood & Cancer. 60: 1817-25. PMID 23798361 DOI: 10.1002/Pbc.24655 |
0.322 |
|
| 2013 |
Malogolowkin MH, Krailo M, Marina N, Olson T, Frazier AL. Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG). Pediatric Blood & Cancer. 60: 1602-1605. PMID 23703725 DOI: 10.1002/Pbc.24601 |
0.464 |
|
| 2013 |
Goldsby RE, Fan TM, Villaluna D, Wagner LM, Isakoff MS, Meyer J, Randall RL, Lee S, Kim G, Bernstein M, Gorlick R, Krailo M, Marina N. Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. European Journal of Cancer (Oxford, England : 1990). 49: 2384-91. PMID 23664013 DOI: 10.1016/J.Ejca.2013.03.018 |
0.474 |
|
| 2013 |
Borinstein SC, Beeler N, Block JJ, Gorlick R, Grohar P, Jedlicka P, Krailo M, Morris C, Phillips S, Siegal GP, Lawlor ER, Lessnick SL. A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group. Frontiers in Oncology. 3: 57. PMID 23519678 DOI: 10.3389/Fonc.2013.00057 |
0.436 |
|
| 2013 |
Rodriguez-Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G. Children's Oncology Group's 2013 blueprint for research: rare tumors. Pediatric Blood & Cancer. 60: 1016-21. PMID 23255219 DOI: 10.1002/Pbc.24428 |
0.469 |
|
| 2013 |
Felgenhauer JL, Nieder ML, Krailo MD, Bernstein ML, Henry DW, Malkin D, Baruchel S, Chuba PJ, Sailer SL, Brown K, Ranganathan S, Marina N. A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893. Pediatric Blood & Cancer. 60: 409-14. PMID 23065953 DOI: 10.1002/Pbc.24328 |
0.451 |
|
| 2013 |
Warwick AB, Malempati S, Krailo M, Melemed A, Gorlick R, Ames MM, Safgren SL, Adamson PC, Blaney SM. Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study. Pediatric Blood & Cancer. 60: 237-241. PMID 22745043 DOI: 10.1002/Pbc.24244 |
0.498 |
|
| 2013 |
Morris C, Teot LA, Bernstein ML, Marina N, Krailo MD, Villaluna D, Gorlick RG, Randall RL. Discordance of oncologic surgical classifications in COG studies. Journal of Clinical Oncology. 31: 10528-10528. DOI: 10.1200/Jco.2013.31.15_Suppl.10528 |
0.345 |
|
| 2013 |
Trobaugh-Lotrario AD, Chaiyachati BH, Meyers R, Haberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo MD, Feusner JH. Outcome in congenital hepatoblastoma compared with previously reported data. Journal of Clinical Oncology. 31: 10037-10037. DOI: 10.1200/Jco.2013.31.15_Suppl.10037 |
0.407 |
|
| 2013 |
Spector LG, Ritter K, Demerath EW, Sklar C, Ross JA, Krailo M, Nagarajan R, Malkin D, Bergemann TL, Savage SA, Johnson W. Abstract 2532: Pediatric osteosarcoma patients are taller than average from birth to age twelve: a report from the Children's Oncology Group. Cancer Research. 73: 2532-2532. DOI: 10.1158/1538-7445.Am2013-2532 |
0.332 |
|
| 2012 |
Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, Weiss AR. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 4148-54. PMID 23091096 DOI: 10.1200/Jco.2011.41.5703 |
0.437 |
|
| 2012 |
Ebb D, Meyers P, Grier H, Bernstein M, Gorlick R, Lipshultz SE, Krailo M, Devidas M, Barkauskas DA, Siegal GP, Ferguson WS, Letson GD, Marcus K, Goorin A, Beardsley P, et al. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2545-51. PMID 22665540 DOI: 10.1200/Jco.2011.37.4546 |
0.448 |
|
| 2012 |
Fligor BJ, Krasker JD, Villaluna D, Krailo M, Frazier AL. “Accelerated ear-age”: A new measure of chemotherapy-induced ototoxicity† Pediatric Blood & Cancer. 59: 947-949. PMID 22492682 DOI: 10.1002/Pbc.24169 |
0.337 |
|
| 2012 |
Puumala SE, Ross JA, Feusner JH, Tomlinson GE, Malogolowkin MH, Krailo MD, Spector LG. Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group. Human Reproduction (Oxford, England). 27: 1649-56. PMID 22473396 DOI: 10.1093/Humrep/Des109 |
0.331 |
|
| 2012 |
Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N. Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group. Cancer. 118: 4597-605. PMID 22252521 DOI: 10.1002/Cncr.27414 |
0.417 |
|
| 2012 |
Malogolowkin MH, Katzenstein HM, Krailo M, Meyers RL. Treatment of hepatoblastoma: the North American cooperative group experience. Frontiers in Bioscience (Elite Edition). 4: 1717-23. PMID 22201987 DOI: 10.2741/492 |
0.405 |
|
| 2012 |
Malempati S, Weigel B, Ingle AM, Ahern CH, Carroll JM, Roberts CT, Reid JM, Schmechel S, Voss SD, Cho SY, Chen HX, Krailo MD, Adamson PC, Blaney SM. Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 256-62. PMID 22184397 DOI: 10.1200/Jco.2011.37.4355 |
0.479 |
|
| 2012 |
Baruchel S, Pappo A, Krailo M, Baker KS, Wu B, Villaluna D, Lee-Scott M, Adamson PC, Blaney SM. A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group. European Journal of Cancer. 48: 579-585. PMID 22088484 DOI: 10.1016/J.Ejca.2011.09.027 |
0.425 |
|
| 2012 |
Potter SL, Berg S, Ingle AM, Krailo M, Adamson PC, Blaney SM. Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962). Pediatric Blood & Cancer. 58: 362-5. PMID 21910214 DOI: 10.1002/Pbc.23317 |
0.44 |
|
| 2012 |
Gilman AL, Schultz KR, Goldman FD, Sale GE, Krailo MD, Chen Z, Langholz B, Jacobsohn DA, Chan KW, Ryan RE, Kellick M, Neudorf SM, Godder K, Sandler ES, Sahdev I, et al. Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 84-91. PMID 21689773 DOI: 10.1016/J.Bbmt.2011.05.016 |
0.431 |
|
| 2012 |
Hale J, Olson TA, Nicholson J, Dang H, Krailo MD, Billmire D, Donachie P, Thornton C, Rodriguez-Galindo C, Frazier AL. Carboplatin (CBP) versus cisplatin (CP) within prognostic groups in pediatric extracranial malignant germ cell tumors (MGCTs). Journal of Clinical Oncology. 30: 9539-9539. DOI: 10.1200/Jco.2012.30.15_Suppl.9539 |
0.435 |
|
| 2012 |
DuBois SG, Krailo MD, Gebhardt MC, Donaldson SS, Marcus KC, Dormans JP, Shamberger RC, Sailer SL, Nicholas RW, Healey JH, Tarbell N, Devidas M, Meyer JS, Granowetter L, Womer R, et al. Evaluation of local control strategies in patients with localized Ewing sarcoma of bone: A report from the Children’s Oncology Group. Journal of Clinical Oncology. 30: 9537-9537. DOI: 10.1200/Jco.2012.30.15_Suppl.9537 |
0.359 |
|
| 2012 |
Kopp LM, Bernstein ML, Schwartz CL, Ebb D, Krailo MD, Grier HE, Meyers PA, Wexler LH, Marina N, Womer R, Janeway KA, Gorlick RG, Lipshultz SE. The effects of dexrazoxane on cardiac status and second malignant neoplasms (SMN) in doxorubicin-treated patients with osteosarcoma (OS). Journal of Clinical Oncology. 30: 9503-9503. DOI: 10.1200/Jco.2012.30.15_Suppl.9503 |
0.381 |
|
| 2012 |
Whelan J, Hook J, Bielack SS, Marina N, Smeland S, Jovic G, Krailo MD, Kühne T, Eriksson M, Butterfass-Bahloul T, Teot LA, Kager L, Gelderblom H, Hall KS, Hogendoorn PCW, et al. EURAMOS-1 study : Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma Journal of Clinical Oncology. 30: 10081-10081. DOI: 10.1200/Jco.2012.30.15_Suppl.10081 |
0.37 |
|
| 2012 |
Musselman J, Bergemann T, Krailo M, Malkin D, Ross J, Savage S, Nagarajan R, Sklar C, Spector L. Abstract LB-333: A case-parent-triad approach in assessing risk of osteosarcoma associated with genetic variation in insulin-like growth factor 1/growth hormone axis genes: a Children's Oncology Group (COG) study Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-333 |
0.334 |
|
| 2011 |
Malogolowkin MH, Katzenstein HM, Meyers RL, Krailo MD, Rowland JM, Haas J, Finegold MJ. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3301-6. PMID 21768450 DOI: 10.1200/Jco.2010.29.3837 |
0.441 |
|
| 2011 |
Hingorani P, Seidel K, Krailo M, Mascarenhas L, Meyers P, Marina N, Conrad EU, Hawkins DS. Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: A report from the Children's Oncology Group Pediatric Blood and Cancer. 57: 939-942. PMID 21480474 DOI: 10.1002/Pbc.23129 |
0.36 |
|
| 2011 |
Anderson JR, Krailo M. The Children's Oncology Group routinely applies "lack of efficacy" interim monitoring to its randomized clinical trials. The American Journal of Bioethics : Ajob. 11: 18-9. PMID 21400379 DOI: 10.1080/15265161.2011.552357 |
0.392 |
|
| 2011 |
Cooper A, van Doorninck J, Ji L, Russell D, Ladanyi M, Shimada H, Krailo M, Womer RB, Hsu JH, Thomas D, Triche TJ, Sposto R, Lawlor ER. Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 56-66. PMID 21047978 DOI: 10.1158/1078-0432.Ccr-10-1417 |
0.401 |
|
| 2011 |
Mascarenhas L, Felgenhauer JL, Bond MC, Femino JD, Laack NN, Ranganathan S, Krailo MD, Marina N. Pilot study of adding vincristine, topotecan, and cyclophosphamide to interval-compressed chemotherapy in newly diagnosed patients with localized Ewing sarcoma family of tumors: A Children's Oncology Group trial. Journal of Clinical Oncology. 29: 9526-9526. DOI: 10.1200/Jco.2011.29.15_Suppl.9526 |
0.389 |
|
| 2011 |
Tilan JU, Mtaweh H, Everhart LM, Long J, Barkauskas DA, Krailo M, Jeha D, Toretsky J, Kitlinska J. Abstract 4352: Systemic levels of neuropeptide Y are elevated in Ewing's sarcoma patients Cancer Research. 71: 4352-4352. DOI: 10.1158/1538-7445.Am2011-4352 |
0.377 |
|
| 2010 |
Pappo AS, Krailo M, Chen Z, Rodriguez-Galindo C, Reaman G. Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 5011-6. PMID 20956621 DOI: 10.1200/Jco.2010.31.2603 |
0.44 |
|
| 2010 |
Beaty O, Berg S, Blaney S, Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PC. A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. Pediatric Blood & Cancer. 55: 440-5. PMID 20658614 DOI: 10.1002/Pbc.22544 |
0.478 |
|
| 2010 |
Chen Z, Krailo MD, Azen SP, Tighiouart M. A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials. Contemporary Clinical Trials. 31: 473-82. PMID 20609419 DOI: 10.1016/J.Cct.2010.05.010 |
0.33 |
|
| 2010 |
George RE, Lahti JM, Adamson PC, Zhu K, Finkelstein D, Ingle AM, Reid JM, Krailo M, Neuberg D, Blaney SM, Diller L. Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study. Pediatric Blood & Cancer. 55: 629-38. PMID 20589651 DOI: 10.1002/Pbc.22607 |
0.469 |
|
| 2010 |
Arndt CA, Koshkina NV, Inwards CY, Hawkins DS, Krailo MD, Villaluna D, Anderson PM, Goorin AM, Blakely ML, Bernstein M, Bell SA, Ray K, Grendahl DC, Marina N, Kleinerman ES. Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4024-30. PMID 20576718 DOI: 10.1158/1078-0432.Ccr-10-0662 |
0.354 |
|
| 2010 |
van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1989-94. PMID 20308669 DOI: 10.1200/Jco.2009.24.5845 |
0.427 |
|
| 2010 |
Jacobs S, Fox E, Krailo M, Hartley G, Navid F, Wexler L, Blaney SM, Goodwin A, Goodspeed W, Balis FM, Adamson PC, Widemann BC. Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 750-4. PMID 20068084 DOI: 10.1158/1078-0432.Ccr-09-1906 |
0.493 |
|
| 2010 |
Leavey P, Bender JLG, Mascarenhas L, Granowetter L, Anderson M, Krailo MD, Gorlick RG, Marina N. Feasibility of bevacizumab (NSC 704865, BB-IND# 7921) combined with vincristine, topotecan, and cyclophosphamide in patients with first recurrent Ewing sarcoma (EWS): A Children's Oncology Group (COG) study. Journal of Clinical Oncology. 28: 9552-9552. DOI: 10.1200/Jco.2010.28.15_Suppl.9552 |
0.389 |
|
| 2010 |
Warwick AB, Malempati S, Krailo MD, Melemed AS, Adamson PC, Blaney S. Phase II trial of pemetrexed in children with refractory solid tumors: A Children's Oncology Group study. Journal of Clinical Oncology. 28: 9535-9535. DOI: 10.1200/Jco.2010.28.15_Suppl.9535 |
0.439 |
|
| 2010 |
Wiener A, Nagarajan R, Hjorth L, Jenney M, Vos PD, Bernstein ML, Krailo MD, Sydes MR, Calaminus G. Quality of life (QoL) in osteosarcoma: First results of the presurgery treatment period of EURAMOS-1 (NCT00134030). Journal of Clinical Oncology. 28: 10062-10062. DOI: 10.1200/Jco.2010.28.15_Suppl.10062 |
0.324 |
|
| 2010 |
Spector LG, Puumala SE, Tomlinson GE, Georgieff MK, Krailo M, Ross JA. Abstract 3774: Congenital abnormalities and hepatoblastoma: A report from the Children's Oncology Group (COG) Cancer Research. 70: 3774-3774. DOI: 10.1158/1538-7445.Am10-3774 |
0.346 |
|
| 2010 |
Puumala SE, Feusner J, Malogolowkin MH, Krailo MD, Ross JA, Spector LG. Abstract 1828: Infertility and hepatoblastoma: A report from the Children's Oncology Group (COG) Cancer Research. 70: 1828-1828. DOI: 10.1158/1538-7445.Am10-1828 |
0.338 |
|
| 2009 |
Malogolowkin MH, Krailo M, Frazier LA, Olson TA. Study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high-risk germ cell tumors: A Children's Oncology Group report. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 10035. PMID 27962582 DOI: 10.1200/Jco.2009.27.15_Suppl.10035 |
0.491 |
|
| 2009 |
Marina N, Bielack S, Whelan J, Smeland S, Krailo M, Sydes MR, Butterfass-Bahloul T, Calaminus G, Bernstein M. International collaboration is feasible in trials for rare conditions: The EURAMOS experience Cancer Treatment and Research. 152: 339-353. PMID 20213400 DOI: 10.1007/978-1-4419-0284-9_18 |
0.375 |
|
| 2009 |
Katzenstein HM, Chang KW, Krailo M, Chen Z, Finegold MJ, Rowland J, Reynolds M, Pappo A, London WB, Malogolowkin M. Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group. Cancer. 115: 5828-35. PMID 19813275 DOI: 10.1002/Cncr.24667 |
0.455 |
|
| 2009 |
Chou AJ, Kleinerman ES, Krailo MD, Chen Z, Betcher DL, Healey JH, Conrad EU, Nieder ML, Weiner MA, Wells RJ, Womer RB, Meyers PA. Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. Cancer. 115: 5339-48. PMID 19637348 DOI: 10.1002/Cncr.24566 |
0.455 |
|
| 2009 |
Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 53: 1016-22. PMID 19588519 DOI: 10.1002/Pbc.22088 |
0.472 |
|
| 2009 |
Kuttesch JF, Krailo MD, Madden T, Johansen M, Bleyer A. Phase II Evaluation of Intravenous Vinorelbine (Navelbine) in Recurrent or Refractory Pediatric Malignancies: A Children's Oncology Group Study Pediatric Blood & Cancer. 53: 590-593. PMID 19533657 DOI: 10.1002/Pbc.22133 |
0.442 |
|
| 2009 |
Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J, Shamberger RC, Goorin A, Miser J, Meyer J, Arndt CA, et al. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2536-41. PMID 19349548 DOI: 10.1200/Jco.2008.19.1478 |
0.413 |
|
| 2009 |
McGregor LM, Spunt SL, Furman WL, Stewart CF, Schaiquevich P, Krailo MD, Speights R, Ivy P, Adamson PC, Blaney SM. Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study. Cancer. 115: 1765-75. PMID 19170226 DOI: 10.1002/Cncr.24175 |
0.492 |
|
| 2009 |
Gilman AL, Ozkaynak MF, Matthay KK, Krailo M, Yu AL, Gan J, Sternberg A, Hank JA, Seeger R, Reaman GH, Sondel PM. Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 85-91. PMID 19047298 DOI: 10.1200/Jco.2006.10.3564 |
0.339 |
|
| 2009 |
Chen Z, Krailo MD, Sun J, Azen SP. Range and trend of expected toxicity level (ETL) in standard A + B designs: a report from the Children's Oncology Group. Contemporary Clinical Trials. 30: 123-8. PMID 19000782 DOI: 10.1016/J.Cct.2008.10.006 |
0.337 |
|
| 2009 |
DuBois SG, Krailo MD, Lessnick SL, Smith R, Chen Z, Marina N, Grier HE, Stegmaier K. Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 52: 324-7. PMID 18989890 DOI: 10.1002/Pbc.21822 |
0.461 |
|
| 2008 |
Chou AJ, Kleinerman E, Krailo MD, Betcher D, Healey J, Nadel H, Nieder M, Weiner M, Wells RJ, Meyers PA. Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 10018. PMID 27951322 DOI: 10.1200/Jco.2008.26.15_Suppl.10018 |
0.456 |
|
| 2008 |
Jacobs S, Fox B, Krailo MD, Hartley G, Navid F, Wexler L, Blaney SM, Frank B, Adamson PC, Widemann BC. Phase II trial of ixabepilone (BMS-247550) in children and young adults with refractory solid tumors: A report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 10026. PMID 27951316 DOI: 10.1200/Jco.2008.26.15_Suppl.10026 |
0.434 |
|
| 2008 |
Shankar SM, Chen L, Zhou T, Krailo MD, Reaman G, Bhatia S. Risk of therapy related myelodysplasia and acute myeloid leukemia (t-MDS/AML) in children exposed to alkylating agents, anthracyclines, platinum compounds and epipodophyllotoxins: a report from Children's Oncology Group (COG). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 10005. PMID 27951253 DOI: 10.1200/Jco.2008.26.15_Suppl.10005 |
0.338 |
|
| 2008 |
O'Leary M, Krailo M, Anderson JR, Reaman GH. Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group. Seminars in Oncology. 35: 484-93. PMID 18929147 DOI: 10.1053/J.Seminoncol.2008.07.008 |
0.442 |
|
| 2008 |
Jakacki RI, Hamilton M, Gilbertson RJ, Blaney SM, Tersak J, Krailo MD, Ingle AM, Voss SD, Dancey JE, Adamson PC. Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study Journal of Clinical Oncology. 26: 4921-4927. PMID 18794549 DOI: 10.1200/Jco.2007.15.2306 |
0.44 |
|
| 2008 |
Bradley KA, Pollack IF, Reid JM, Adamson PC, Ames MM, Vezina G, Blaney S, Ivy P, Zhou T, Krailo M, Reaman G, Mehta MP. Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study. Neuro-Oncology. 10: 752-8. PMID 18715950 DOI: 10.1215/15228517-2008-043 |
0.363 |
|
| 2008 |
Raetz EA, Cairo MS, Borowitz MJ, Blaney SM, Krailo MD, Leil TA, Reid JM, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC. Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3756-62. PMID 18669463 DOI: 10.1200/Jco.2007.15.3528 |
0.43 |
|
| 2008 |
Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 51: 334-8. PMID 18506764 DOI: 10.1002/Pbc.21618 |
0.451 |
|
| 2008 |
Malogolowkin MH, Katzenstein HM, Krailo M, Chen Z, Quinn JJ, Reynolds M, Ortega JA. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2379-83. PMID 18467729 DOI: 10.1200/Jco.2006.09.7204 |
0.473 |
|
| 2008 |
Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 633-8. PMID 18235123 DOI: 10.1200/Jco.2008.14.0095 |
0.405 |
|
| 2008 |
Glade Bender JL, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-Qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, Blaney SM, Kandel JJ, et al. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 399-405. PMID 18202416 DOI: 10.1200/Jco.2007.11.9230 |
0.446 |
|
| 2008 |
Fujii H, Cuvelier G, She K, Aslanian S, Shimizu H, Kariminia A, Krailo M, Chen Z, McMaster R, Bergman A, Goldman F, Grupp SA, Wall DA, Gilman AL, Schultz KR. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood. 111: 3276-85. PMID 17925486 DOI: 10.1182/Blood-2007-08-106286 |
0.394 |
|
| 2008 |
Franklin JL, Seibel NL, Krailo M, Fu C, Adamson PC, Reaman G. Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report. Pediatric Blood & Cancer. 50: 533-6. PMID 17668867 DOI: 10.1002/Pbc.21313 |
0.494 |
|
| 2008 |
Horton TM, Ames MM, Reid JM, Krailo MD, Pendergrass T, Mosher R, Reaman GH, Seibel NL. A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study. Pediatric Blood & Cancer. 50: 788-92. PMID 17668866 DOI: 10.1002/Pbc.21310 |
0.398 |
|
| 2008 |
Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Blaney SM, Adamson PC. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatric Blood & Cancer. 50: 254-8. PMID 17262795 DOI: 10.1002/Pbc.21132 |
0.496 |
|
| 2008 |
Womer RB, West DC, Krailo MD, Dickman PS, Pawel B. Randomized comparison of every-two-week v. every-three-week chemotherapy in Ewing sarcoma family tumors (ESFT) Journal of Clinical Oncology. 26: 10504-10504. DOI: 10.1200/Jco.2008.26.15_Suppl.10504 |
0.402 |
|
| 2008 |
Malogolowkin MH, Katzenstein HM, Krailo MD, Rowland J, Haas J, Meyers R, Finegold MJ. Complete surgical resection for children with pure fetal histology hepatoblastoma (PFH): A report of the Childrens Oncology Group (COG) Journal of Clinical Oncology. 26: 10049-10049. DOI: 10.1200/Jco.2008.26.15_Suppl.10049 |
0.465 |
|
| 2008 |
Ayello J, Berg SL, Krailo M, Ven Cvd, Ingle AM, Lewis D, Harrison L, Blaney S, Adamson PC, Cairo MS. Lenalidomide (LMID) Significantly Enhances Circulating Serum Levels of IL-2 and IL-15 Levels, NK Expansion and Activation and NK and LAK Cytotoxicity in Children with Refractory/Recurrent Solid Tumors: A Children’s Oncology Group Phase I Consortium Report Blood. 112: 107-107. DOI: 10.1182/Blood.V112.11.107.107 |
0.334 |
|
| 2007 |
Bomgaars LR, Bernstein M, Krailo M, Kadota R, Das S, Chen Z, Adamson PC, Blaney SM. Phase II trial of irinotecan in children with refractory solid tumors: A Children's Oncology Group study Journal of Clinical Oncology. 25: 4622-4627. PMID 17925558 DOI: 10.1200/Jco.2007.11.6103 |
0.455 |
|
| 2007 |
Cooney-Qualter E, Krailo M, Angiolillo A, Fawwaz RA, Wiseman G, Harrison L, Kohl V, Adamson PC, Ayello J, vande Ven C, Perkins SL, Cairo MS. A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5652s-5660s. PMID 17875803 DOI: 10.1158/1078-0432.Ccr-07-1060 |
0.418 |
|
| 2007 |
Nicholson HS, Kretschmar CS, Krailo M, Bernstein M, Kadota R, Fort D, Friedman H, Harris MB, Tedeschi-Blok N, Mazewski C, Sato J, Reaman GH. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group. Cancer. 110: 1542-50. PMID 17705175 DOI: 10.1002/Cncr.22961 |
0.503 |
|
| 2007 |
Miser JS, Goldsby RE, Chen Z, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore SG, Rausen AR, et al. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatric Blood & Cancer. 49: 894-900. PMID 17584910 DOI: 10.1002/Pbc.21233 |
0.433 |
|
| 2007 |
Schwartz CL, Gorlick R, Teot L, Krailo M, Chen Z, Goorin A, Grier HE, Bernstein ML, Meyers P. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 2057-62. PMID 17513810 DOI: 10.1200/Jco.2006.07.7776 |
0.366 |
|
| 2007 |
Rheingold SR, Hogarty MD, Blaney SM, Zwiebel JA, Sauk-Schubert C, Chandula R, Krailo MD, Adamson PC. Phase I Trial of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Doxorubicin and Cyclophosphamide in Children With Relapsed Solid Tumors: A Children's Oncology Group Study Journal of Clinical Oncology. 25: 1512-1518. PMID 17442993 DOI: 10.1200/Jco.2006.09.5125 |
0.415 |
|
| 2007 |
Malempati S, Nicholson HS, Reid JM, Blaney SM, Ingle AM, Krailo M, Stork LC, Melemed AS, McGovern R, Safgren S, Ames MM, Adamson PC. Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: The Children's Oncology Group Journal of Clinical Oncology. 25: 1505-1511. PMID 17442992 DOI: 10.1200/Jco.2006.09.1694 |
0.503 |
|
| 2007 |
Weigel BJ, Blaney SM, Reid JM, Safgren SL, Bagatell R, Kersey J, Neglia JP, Ivy SP, Ingle AM, Whitesell L, Gilbertson RJ, Krailo M, Ames M, Adamson PC. A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study. Clinical Cancer Research. 13: 1789-1793. PMID 17363534 DOI: 10.1158/1078-0432.Ccr-06-2270 |
0.394 |
|
| 2007 |
Seibel NL, Krailo M, Chen Z, Healey J, Breitfeld PP, Drachtman R, Greffe B, Nachman J, Nadel H, Sato JK, Meyers PA, Reaman GH. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943. Cancer. 109: 1646-53. PMID 17334983 DOI: 10.1002/Cncr.22553 |
0.475 |
|
| 2007 |
Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, Rausen AR, Robison LL, Vietti TJ, Miser JS. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood. 109: 46-51. PMID 16985182 DOI: 10.1182/Blood-2006-01-023101 |
0.432 |
|
| 2007 |
Su Y, Davies S, Davis M, Lu H, Giller R, Krailo M, Cai Q, Robison L, Shu X. Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: A report from the Children’s Oncology Group Cancer Letters. 247: 204-212. PMID 16759797 DOI: 10.1016/J.Canlet.2006.04.010 |
0.33 |
|
| 2007 |
Jimeno A, Daw NC, Amador ML, Cusatis G, Kulesza P, Krailo M, Ingle AM, Blaney SM, Adamson P, Hidalgo M. Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors. Pediatric Blood & Cancer. 49: 352-7. PMID 16425266 DOI: 10.1002/Pbc.20753 |
0.376 |
|
| 2007 |
George R, Lahti J, Ingle M, Krailo M, Blaney S, Adamson P, Murgo A, Kidd V, Diller L. Decitabine (DAC) in combination with doxorubicin (DOX) and cyclophosphamide (CTX) in relapsed neuroblastoma (NBL): A Children's Oncology Group Study Journal of Clinical Oncology. 25: 9565-9565. DOI: 10.1200/Jco.2007.25.18_Suppl.9565 |
0.443 |
|
| 2007 |
Raetz EA, Cairo MS, Borowitz MJ, Blaney SM, Krailo MD, Leil TA, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC. Chemoimmunotherapy reinduction with epratuzumab in children with ALL with marrow relapse: A Children's Oncology Group (COG) pilot study (ADVL04P2) Journal of Clinical Oncology. 25: 9513-9513. DOI: 10.1200/Jco.2007.25.18_Suppl.9513 |
0.415 |
|
| 2007 |
DuBois SG, Krailo MD, Cook EF, Tarbell NJ, Fryer CJ, Gebhardt MC, Brown K, Miser JS, Marina NM, Grier HE. Evaluation of local control in patients with non-metastatic Ewing sarcoma of the bone: A report from the Children's Oncology Group Journal of Clinical Oncology. 25: 10013-10013. DOI: 10.1200/Jco.2007.25.18_Suppl.10013 |
0.363 |
|
| 2007 |
Leavey P, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Bernstein M, Granowetter L, Grier H. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence Journal of Clinical Oncology. 25: 10011-10011. DOI: 10.1200/Jco.2007.25.18_Suppl.10011 |
0.397 |
|
| 2006 |
Jakacki RI, Tersak J, Blaney S, Krailo M, Hamilton M, Dancy J, Gilbertson R, Ingle A, Adamson PC. A pediatric phase I trial and pharmacokinetic (PK) study of erlotinib (ERL) followed by the combination of ERL with temozolomide (TMZ): A Children's Oncology Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 9015. PMID 27954200 DOI: 10.1200/Jco.2006.24.18_Suppl.9015 |
0.424 |
|
| 2006 |
Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, Bernstein M, Laurie F, Gebhardt MC, Grier HE, Tarbell NJ. Local control in pelvic Ewing sarcoma: Analysis from INT-0091 - A report from the children's oncology group Journal of Clinical Oncology. 24: 3838-3843. PMID 16921035 DOI: 10.1200/Jco.2006.05.9188 |
0.353 |
|
| 2006 |
Fouladi M, Furman WL, Chin T, Freeman BB, Dudkin L, Stewart CF, Krailo MD, Speights R, Ingle AM, Houghton PJ, Wright J, Adamson PC, Blaney SM. Phase I study of depsipeptide in pediatric patients with refractory solid tumors: A children's oncology group report Journal of Clinical Oncology. 24: 3678-3685. PMID 16877737 DOI: 10.1200/Jco.2006.06.4964 |
0.414 |
|
| 2006 |
Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, Reynolds CP. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709). Journal of Clinical Oncology. 24: 3423-3430. PMID 16849757 DOI: 10.1200/Jco.2005.03.9271 |
0.439 |
|
| 2006 |
Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2879-84. PMID 16782927 DOI: 10.1200/Jco.2005.02.6013 |
0.438 |
|
| 2006 |
Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM, et al. A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1750-9. PMID 16551859 DOI: 10.1158/1078-0432.Ccr-05-2000 |
0.377 |
|
| 2006 |
Zwerdling T, Krailo M, Monteleone P, Byrd R, Sato J, Dunaway R, Seibel N, Chen Z, Strain J, Reaman G. Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children's Oncology Group. Cancer. 106: 1821-8. PMID 16532433 DOI: 10.1002/Cncr.21779 |
0.464 |
|
| 2006 |
Hawkins DS, Bradfield S, Whitlock JA, Krailo M, Franklin J, Blaney SM, Adamson PC, Reaman G. Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study. Pediatric Blood & Cancer. 47: 790-4. PMID 16435380 DOI: 10.1002/Pbc.20739 |
0.486 |
|
| 2006 |
Johansen M, Kuttesch J, Bleyer WA, Krailo M, Ames M, Madden T. Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group. Clinical Cancer Research. 12: 516-522. PMID 16428494 DOI: 10.1158/1078-0432.Ccr-05-1541 |
0.397 |
|
| 2006 |
MPHSSMD, SDMD, Giller R, Krailo M, Davis M, Gardner K, Cai H, Robison L, XSMD. In utero exposure to female hormones and germ cell tumors in children. Cancer. 106: 1169-1177. PMID 16421921 DOI: 10.1002/Cncr.21670 |
0.335 |
|
| 2006 |
Warren K, Jakacki R, Widemann B, Aikin A, Libucha M, Packer R, Vezina G, Reaman G, Shaw D, Krailo M, Osborne C, Cehelsky J, Caldwell D, Stanwood J, Steinberg SM, et al. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group. Cancer Chemotherapy and Pharmacology. 58: 343-347. PMID 16408203 DOI: 10.1007/S00280-005-0172-7 |
0.435 |
|
| 2006 |
Chen Z, Robison L, Giller R, Krailo M, Davis M, Davies S, Shu X. Environmental exposure to residential pesticides, chemicals, dusts, fumes, and metals, and risk of childhood germ cell tumors. International Journal of Hygiene and Environmental Health. 209: 31-40. PMID 16373200 DOI: 10.1016/J.Ijheh.2005.08.001 |
0.3 |
|
| 2006 |
Angiolillo AL, Whitlock J, Chen Z, Krailo M, Reaman G. Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): a Children's Oncology Group Report. Pediatric Blood & Cancer. 46: 193-7. PMID 15929131 DOI: 10.1002/Pbc.20419 |
0.403 |
|
| 2006 |
Horton TM, Thompson PA, Bomgaars LR, Adamson PC, Krailo M, Ingle A, Blaney SM. A phase I study of bortezomib (PS-341) in pediatric patients with relapsed or refractory leukemia: A Children’s Oncology Group study Journal of Clinical Oncology. 24: 9021-9021. DOI: 10.1200/Jco.2006.24.18_Suppl.9021 |
0.422 |
|
| 2006 |
Nicholson HS, Blaney SM, Ingle AM, Krailo M, Stork LC, Ames MM, Adamson PC. Pediatric phase 1 study of pemetrexed: A report from the Children’s Oncology Group Journal of Clinical Oncology. 24: 9019-9019. DOI: 10.1200/Jco.2006.24.18_Suppl.9019 |
0.416 |
|
| 2006 |
Weigel B, Blaney S, Kersey J, Bagatell R, Ivy SP, Whitesell L, Krailo M, Reid J, Ames M, Adamson P. A phase I study of 17-AAG in relapsed/refractory pediatric patients with solid tumors: A Children's Oncology Groups study Journal of Clinical Oncology. 24: 9018-9018. DOI: 10.1200/Jco.2006.24.18_Suppl.9018 |
0.483 |
|
| 2005 |
Bradfield S, Hawkins DS, Whitlock J, Krailo M, Franklin J, Adamson PC. Phase II study of 21 day continuous intravenous infusion (CIVI) topotecan for recurrent pediatric solid tumors: A Children's Oncology Group Study (COG A09713). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8523. PMID 27944626 DOI: 10.1200/Jco.2005.23.16_Suppl.8523 |
0.431 |
|
| 2005 |
Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Fouladi M, Hill DA, Heinrich M, Blaney S, Adamson PC. Phase 2 trial of imatinib mesylate (IM) for treatment of recurrent or refractory pediatric solid tumors: A Children's Oncology Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8520. PMID 27944624 DOI: 10.1200/Jco.2005.23.16_Suppl.8520 |
0.42 |
|
| 2005 |
Fouladi M, Furman WL, Chin T, Freeman B, Stewart CF, Krailo M, Houghton PJ, Wright J, Adamson PC, Blaney SM. A phase I trial of depsipeptide in children with refractory solid tumors: A Children's Oncology Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8528. PMID 27944614 DOI: 10.1200/Jco.2005.23.16_Suppl.8528 |
0.425 |
|
| 2005 |
Bhatia S, Krailo M, Chen Z, Burden L, Dickman P, Grier H, Link M, Meyers P, Perlman E, Robison LL, Miser J. Therapy-related myelodysplasia/ leukemia (t-MDS/AML) following treatment of children with Ewing sarcoma and primitive neuroectodermal tumor of bone (PNET). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8514. PMID 27944596 DOI: 10.1200/Jco.2005.23.16_Suppl.8514 |
0.373 |
|
| 2005 |
Whitlock JA, Krailo M, Reid JM, Ruben SL, Ames MM, Owen W, Reaman G. Phase I Clinical and Pharmacokinetic Study of Flavopiridol in Children With Refractory Solid Tumors: A Children's Oncology Group Study Journal of Clinical Oncology. 23: 9179-9186. PMID 16361620 DOI: 10.1200/Jco.2004.01.0660 |
0.417 |
|
| 2005 |
Chen Z, Stewart PA, Davies S, Giller R, Krailo M, Davis M, Robison L, Shu XO. Parental occupational exposure to pesticides and childhood germ-cell tumors. American Journal of Epidemiology. 162: 858-67. PMID 16192347 DOI: 10.1093/Aje/Kwi294 |
0.302 |
|
| 2005 |
Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca JG, Chiba A, Reaman G. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas. Cancer. 104: 1968-74. PMID 16177987 DOI: 10.1002/cncr.21403 |
0.342 |
|
| 2005 |
Daw NC, Furman WL, Stewart CF, Iacono LC, Krailo M, Bernstein ML, Dancey JE, Speights RA, Blaney SM, Croop JM, Reaman GH, Adamson PC. Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6172-80. PMID 16135484 DOI: 10.1200/Jco.2005.11.429 |
0.418 |
|
| 2005 |
Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca JG, Chiba A, Reaman G. Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas. Cancer. 104: 1281-7. PMID 16078267 DOI: 10.1002/Cncr.21301 |
0.504 |
|
| 2005 |
Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: A report from the children's oncology group Journal of Clinical Oncology. 23: 3376-3382. PMID 15908649 DOI: 10.1200/Jco.2005.03.426 |
0.437 |
|
| 2005 |
Angiolillo AL, Davenport V, Bonilla MA, van de Ven C, Ayello J, Militano O, Miller LL, Krailo M, Reaman G, Cairo MS. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 2644-50. PMID 15814645 DOI: 10.1158/1078-0432.Ccr-04-1959 |
0.422 |
|
| 2005 |
Ozkaynak MF, Krailo M, Chen Z, Feusner J. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 45: 274-80. PMID 15806544 DOI: 10.1002/Pbc.20366 |
0.345 |
|
| 2005 |
Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2004-11. PMID 15774791 DOI: 10.1200/Jco.2005.06.031 |
0.383 |
|
| 2005 |
Lau L, Supko JG, Blaney S, Hershon L, Seibel N, Krailo M, Qu W, Malkin D, Jimeno J, Bernstein M, Baruchel S. A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study Clinical Cancer Research. 11: 672-677. PMID 15701855 |
0.354 |
|
| 2005 |
Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, Reaman G, Cairo MS. Ifosfamide, Carboplatin, and Etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: The Children's Cancer Group (CCG) experience Pediatric Blood and Cancer. 44: 338-347. PMID 15503297 DOI: 10.1002/Pbc.20227 |
0.464 |
|
| 2005 |
George RE, Medeiros-Nancarrow C, Adamson PC, Blaney SM, Kidd V, Lahti JM, Krailo M, Look AT, Diller L. A phase I study of decitabine (DCT) in combination with doxorubicin (DOX) and cyclophosphamide (CTX) in the treatment of relapsed or refractory solid tumors: A Children’s Oncology Group Study Journal of Clinical Oncology. 23: 8530-8530. DOI: 10.1200/Jco.2005.23.16_Suppl.8530 |
0.444 |
|
| 2005 |
Kuttesch JF, Krailo MD, Bleyer WA, Reaman GH. Phase II evaluation of vinorelbine in recurrent pediatric malignancies Journal of Clinical Oncology. 23: 8521-8521. DOI: 10.1200/Jco.2005.23.16_Suppl.8521 |
0.436 |
|
| 2005 |
Rheingold S, Krailo M, Blaney S, Hogarty M, Mascarenhas L, Adlard K, Barnich M, Murphy J, Chandula R, Adamson P. A phase I trial of G3139 (Bcl-2 Antisense) combined with cytotoxic chemotherapy in relapsed pediatric solid tumors - A Children's Oncology Group Study Journal of Clinical Oncology. 23: 3102-3102. DOI: 10.1200/Jco.2005.23.16_Suppl.3102 |
0.436 |
|
| 2005 |
Jacobsohn DA, Schultz KR, Goldman F, Wall DA, Krailo M, Chen Z, Lipton JM, Sanders JE, Gilman AL. Eosinophilia, Positive ANA, and Hypergammaglobulinemia at Presentation of Extensive Chronic GVHD in Children: A Children’s Oncology Group Study. Blood. 106: 5375-5375. DOI: 10.1182/Blood.V106.11.5375.5375 |
0.389 |
|
| 2005 |
Cairo MS, Cooney E, Krailo M, Belanger R, Perkins SL, Fawwaz R, Angiolillo A, Adamson P. A Phase I Study of 90Y-Ibritumomab-Tiuxetan (90Y-It) in Children with Recurrent/Refractory CD20 Positive Lymphoma: A Cog Phase I Consortium Study. Blood. 106: 2448-2448. DOI: 10.1182/Blood.V106.11.2448.2448 |
0.346 |
|
| 2004 |
Katzenstein HM, Chang K, Krailo M, Bowman L, Greffe B, Castleberry R, Malogolowkin M. A randomized study of platinum based chemotherapy with or without amifostine for the treatment of children with hepatoblastoma (HB): A report of the Intergroup Hepatoblastoma Study P9645. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 8518. PMID 28013777 DOI: 10.1200/Jco.2004.22.14_Suppl.8518 |
0.467 |
|
| 2004 |
Daw NC, Furman WL, Stewart CF, Iacono LC, Krailo M, Bernstein M, Dancey JE, Blaney S, Adamson PC. A phase I trial and pharmacokinetic study of gefitinib in pediatric patients with refractory solid tumors: A Children's Oncology Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 8522. PMID 28013760 DOI: 10.1200/Jco.2004.22.14_Suppl.8522 |
0.412 |
|
| 2004 |
Blaney SM, Bernstein M, Neville K, Ginsberg J, Kitchen B, Horton T, Berg SL, Krailo M, Adamson PC. Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4804-9. PMID 15570082 DOI: 10.1200/Jco.2004.12.185 |
0.483 |
|
| 2004 |
Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2873-6. PMID 15254055 DOI: 10.1200/Jco.2004.01.041 |
0.45 |
|
| 2004 |
Champagne MA, Capdeville R, Krailo M, Qu W, Peng B, Rosamilia M, Therrien M, Zoellner U, Blaney SM, Bernstein M. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study. Blood. 104: 2655-60. PMID 15231574 DOI: 10.1182/Blood-2003-09-3032 |
0.418 |
|
| 2004 |
Reid JM, Qu W, Safgren SL, Ames MM, Krailo MD, Seibel NL, Kuttesch J, Holcenberg J. Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2445-51. PMID 15197207 DOI: 10.1200/Jco.2004.10.142 |
0.46 |
|
| 2004 |
Aquino VM, Weittnan SD, Winick NJ, Blaney S, Furman WL, Kepner JL, Bonate P, Krailo M, Qu W, Bernstein M. Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: A pediatric oncology group study Journal of Clinical Oncology. 22: 1413-1419. PMID 15084615 DOI: 10.1200/Jco.2004.07.111 |
0.457 |
|
| 2004 |
Malogolowkin MH, Katzenstein H, Krailo M, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Castleberry R. Intensive versus standard platinum therapy for the treatment of children with hepatoblastoma (HB): A report of the Intergroup Hepatoblastoma Study P9645 Journal of Clinical Oncology. 22: 8516-8516. DOI: 10.1200/Jco.2004.22.90140.8516 |
0.46 |
|
| 2004 |
Osenga K, Hank J, Albertini M, Gan J, Sternberg A, Seeger R, Matthay K, Reynolds P, Krailo M, Adamson P, Reisfeld R, Gillies S, Sondel P. A Phase I Trial of Immunocytokine HU14.18-IL2 in Children with Recurrent or Refractory Neuroblastoma and Other GD2 Positive Malignancies: A Study of the Children's Oncology Group Journal of Immunotherapy. 27: S55-S56. DOI: 10.1097/00002371-200411000-00198 |
0.426 |
|
| 2004 |
Yock TI, Krailo MD, Grier HE, Miser JS, Donaldson SS, Fry CJ, Gebhardt MC, Tarbell NJ. A comparison of local control achieved by surgery and radiotherapy in patients with non-metastatic pelvic Ewing sarcoma enrolled on INT-0091 International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.07.014 |
0.311 |
|
| 2003 |
Shamberger RC, LaQuaglia MP, Gebhardt MC, Neff JR, Tarbell NJ, Marcus KC, Sailer SL, Womer RB, Miser JS, Dickman PS, Perlman EJ, Devidas M, Linda SB, Krailo MD, Grier HE, et al. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Annals of Surgery. 238: 563-7; discussion 56. PMID 14530727 DOI: 10.1097/01.Sla.0000089857.45191.52 |
0.362 |
|
| 2003 |
Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 97: 2006-12. PMID 12673731 DOI: 10.1002/Cncr.11292 |
0.34 |
|
| 2003 |
Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP. A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952. Neuro-Oncology. 5: 8-13. PMID 12626128 DOI: 10.1093/Neuonc/5.1.8 |
0.381 |
|
| 2003 |
Liu L, Krailo M, Reaman GH, Bernstein L. Childhood cancer patients' access to cooperative group cancer programs: a population-based study. Cancer. 97: 1339-45. PMID 12599243 DOI: 10.1002/Cncr.11192 |
0.395 |
|
| 2003 |
Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. The New England Journal of Medicine. 348: 694-701. PMID 12594313 DOI: 10.1056/Nejmoa020890 |
0.413 |
|
| 2003 |
Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, et al. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. British Journal of Haematology. 120: 660-70. PMID 12588354 DOI: 10.1046/J.1365-2141.2003.04134.X |
0.398 |
|
| 2002 |
Steinherz PG, Seibel NL, Ames MM, Avramis VI, Krailo MD, Liu-Mares W, Reid JM, Safgren SL, Reaman GH. Phase I Study of Gemcitabine (Difluorodeoxycytidine) in Children with Relapsed or Refractory Leukemia (CCG-0955): A Report from the Children's Cancer Group Leukemia & Lymphoma. 43: 1945-1950. PMID 12481889 DOI: 10.1080/1042819021000015880 |
0.434 |
|
| 2002 |
Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2789-97. PMID 12065555 DOI: 10.1200/Jco.2002.06.155 |
0.412 |
|
| 2002 |
Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E, Laver JH, Reaman GH, Cairo MS. Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 13: 460-9. PMID 11996479 DOI: 10.1093/Annonc/Mdf028 |
0.443 |
|
| 2002 |
Wells RJ, Reid JM, Ames MM, Mares WL, Krailo MD, Seibel NL, Mosher R, Reaman GH, Wiersma SR. Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942 Journal of Pediatric Hematology Oncology. 24: 89-93. PMID 11990712 DOI: 10.1097/00043426-200202000-00006 |
0.431 |
|
| 2002 |
Cairo MS, Krailo MD, Morse M, Hutchinson RJ, Harris RE, Kjeldsberg CR, Kadin ME, Radel E, Steinherz LJ, Morris E, Finlay JL, Meadows AT. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia. 16: 594-600. PMID 11960338 DOI: 10.1038/Sj.Leu.2402402 |
0.462 |
|
| 2001 |
Dinndorf P, Krailo M, Liu-Mares W, Frierdich S, Sondel P, Reaman G. Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemia and lymphoma. Journal of Immunotherapy. 24: 511-516. PMID 11759074 DOI: 10.1097/00002371-200111000-00008 |
0.348 |
|
| 2001 |
Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg C, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Medical and Pediatric Oncology. 37: 432-441. PMID 11745871 DOI: 10.1002/Mpo.1226 |
0.47 |
|
| 2001 |
Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, Baker DL, Davis JH, Gerbing RB, Grovas A, Herzog CE, Lindsley KL, Liu-Mares W, Nachman JB, Sieger L, et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 2812-20. PMID 11387352 DOI: 10.1200/Jco.2001.19.11.2812 |
0.388 |
|
| 2001 |
Arndt CAS, Krailo MD, Liu-Mares W, PMAMD, Reaman GH. Phase I study of CI-958 in children and adolescents with recurrent solid tumors. Cancer. 91: 1166-1169. PMID 11267962 DOI: 10.1002/1097-0142(20010315)91:6<1166::Aid-Cncr1113>3.0.Co;2-Y |
0.433 |
|
| 2001 |
Cairo MS, Shen V, Krailo MD, Bauer M, Miser JS, Sato JK, Blatt J, Blazar BR, Frierdich S, Liu-Mares W, Reaman GH. Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report. Journal of Pediatric Hematology/Oncology. 23: 30-8. PMID 11196267 DOI: 10.1097/00043426-200101000-00008 |
0.432 |
|
| 2001 |
Rescorla F, Billmire D, Stolar C, Vinocur C, Colombani P, Cullen J, Giller R, Cushing B, Lauer S, Davis M, Hawkins E, Shuster J, Krailo M. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: A pediatric intergroup trial (POG 9049/CCG 8882) Journal of Pediatric Surgery. 36: 12-17. PMID 11150431 DOI: 10.1053/Jpsu.2001.19993 |
0.443 |
|
| 2000 |
Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC. Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 4077-85. PMID 11118469 DOI: 10.1200/Jco.2000.18.24.4077 |
0.311 |
|
| 2000 |
Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, Haas JE, King DR, Liu-Mares W, Sensel MG, Krailo MD. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 2665-75. PMID 10894865 DOI: 10.1200/Jco.2000.18.14.2665 |
0.413 |
|
| 2000 |
Fernandez MC, Krailo MD, Gerbing RR, Matthay KK. A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma. Cancer. 88: 2838-2844. PMID 10870069 DOI: 10.1002/1097-0142(20000615)88:12<2838::Aid-Cncr25>3.0.Co;2-9 |
0.415 |
|
| 2000 |
Shamberger RC, Laquaglia MP, Krailo MD, Miser JS, Pritchard DJ, Gebhardt MC, Healey JH, Tarbell NJ, Fryer CJ, Meyers PA, Grier HE. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. The Journal of Thoracic and Cardiovascular Surgery. 119: 1154-61. PMID 10838532 DOI: 10.1067/Mtc.2000.106330 |
0.327 |
|
| 1999 |
Marina NM, Cushing B, Giller R, Cohen L, Lauer SJ, Ablin A, Weetman R, Cullen J, Rogers P, Vinocur C, Stolar C, Rescorla F, Hawkins E, Heifetz S, Rao PV, ... Krailo M, et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 2137-43. PMID 10561269 DOI: 10.1200/Jco.1999.17.7.2137 |
0.451 |
|
| 1999 |
Cushing B, Giller R, Ablin A, Cohen L, Cullen J, Hawkins E, Heifetz SA, Krailo M, Lauer SJ, Marina N, Rao PV, Rescorla F, Vinocur CD, Weetman RM, Castleberry RP. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. American Journal of Obstetrics and Gynecology. 181: 353-8. PMID 10454682 DOI: 10.1016/S0002-9378(99)70561-2 |
0.471 |
|
| 1999 |
Bussey KJ, Lawce HJ, Olson SB, Arthur DC, Kalousek DK, Krailo M, Giller R, Heifetz S, Womer R, Magenis RE. Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences--a Children's Cancer Group study. Genes, Chromosomes & Cancer. 25: 134-46. PMID 10337997 DOI: 10.1002/(Sici)1098-2264(199906)25:2<134::Aid-Gcc9>3.0.Co;2-Y |
0.345 |
|
| 1999 |
Anderson B, Krailo M, Davenport V, Martorella A, Bracho F, Reaman G, Cairo M. #505 Ifosfamide, carboplatin and etoposide (ICE) is a superb retrieval regimen in a large cohort (n = 107) of children with recurrent/refractory soft tissue sarcomas (STS): the Childrenʼs Cancer Group (CCG) experience Journal of Pediatric Hematology Oncology. 21: 337. DOI: 10.1097/00043426-199907000-00132 |
0.379 |
|
| 1999 |
Widemann BC, Balis FM, Reaman GH, Sato J, O'Brien M, Krailo M, Lowery C, Adamson PC. Pediatric phase I trial and pharmacokinetic study of ‘Tomudex’ (Ralitrexed) European Journal of Cancer. 35. DOI: 10.1016/S0959-8049(99)81572-X |
0.305 |
|
| 1998 |
Cairo MS, Krailo MD, Weinthal JA, Secola R, Bergeron S, Ven Cvd, Blazar BR, Garrison L, Reaman GH. A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group. Cancer. 83: 1449-1460. PMID 9762948 DOI: 10.1002/(Sici)1097-0142(19981001)83:7<1449::Aid-Cncr24>3.0.Co;2-3 |
0.468 |
|
| 1998 |
Nicholson HS, Krailo M, Ames MM, Seibel NL, Reid JM, Liu-Mares W, Vezina LG, Ettinger AG, Reaman GH. Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group. Journal of Clinical Oncology. 16: 3037-3043. PMID 9738573 DOI: 10.1200/Jco.1998.16.9.3037 |
0.46 |
|
| 1998 |
Arndt CAS, Krailo MD, Steinherz L, Scheithauer B, Liu-Mares W, Reaman GH. A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors. Cancer. 83: 813-816. PMID 9708950 DOI: 10.1002/(Sici)1097-0142(19980815)83:4<813::Aid-Cncr27>3.0.Co;2-U |
0.449 |
|
| 1998 |
Sievers EL, Lange BJ, Sondel PM, Krailo MD, Gan J, Liu-Mares W, Feig SA. Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 914-9. PMID 9508173 DOI: 10.1200/Jco.1998.16.3.914 |
0.42 |
|
| 1998 |
Hutchinson RJ, Fryer CJ, Davis PC, Nachman J, Krailo MD, O'Brien RT, Collins RD, Whalen T, Reardon D, Trigg ME, Gilchrist GS. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 897-906. PMID 9508171 DOI: 10.1200/Jco.1998.16.3.897 |
0.454 |
|
| 1997 |
Dinndorf PA, Avramis VI, Wiersma S, Krailo MD, Liu-Mares W, Seibel NL, Sato JK, Mosher RB, Kelleher JF, Reaman GH. Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children's Cancer Group. Journal of Clinical Oncology. 15: 2780-2785. PMID 9256119 DOI: 10.1200/Jco.1997.15.8.2780 |
0.432 |
|
| 1997 |
Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM. A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer. 80: 317-33. PMID 9217046 DOI: 10.1002/(Sici)1097-0142(19970715)80:2<317::Aid-Cncr21>3.0.Co;2-W |
0.351 |
|
| 1997 |
Ettinger LJ, Ivy P, Gaynon PS, Ettinger AG, Liu‐Mares W, Krailo MD. A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group. Cancer. 80: 311-316. PMID 9217045 DOI: 10.1002/(Sici)1097-0142(19970715)80:2<311::Aid-Cncr20>3.0.Co;2-W |
0.442 |
|
| 1997 |
Blaney SM, Seibel NL, O'Brien M, Reaman GH, Berg SL, Adamson PC, Poplack DG, Krailo MD, Mosher R, Balis FM. Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 1538-43. PMID 9193350 DOI: 10.1200/Jco.1997.15.4.1538 |
0.477 |
|
| 1997 |
Van Tornout JM, Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 1190-7. PMID 9060563 DOI: 10.1200/Jco.1997.15.3.1190 |
0.434 |
|
| 1997 |
Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group Journal of Clinical Oncology. 15: 76-84. PMID 8996127 DOI: 10.1200/Jco.1997.15.1.76 |
0.449 |
|
| 1995 |
Geyer JR, Balis FM, Krailo MD, Heideman R, Broxson E, Sato JK, Poplack D, Bleyer WA. A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study. Investigational New Drugs. 13: 337-342. PMID 8824353 DOI: 10.1007/Bf00873141 |
0.508 |
|
| 1995 |
Tubergen DG, Krailo MD, Meadows AT, Rosenstock J, Kadin M, Morse M, King D, Steinherz PG, Kersey JH. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. Journal of Clinical Oncology. 13: 1368-1376. PMID 7751881 DOI: 10.1200/Jco.1995.13.6.1368 |
0.457 |
|
| 1995 |
Shu XO, Nesbit ME, Buckley JD, Krailo MD, Robinson LL. An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States). Cancer Causes & Control : Ccc. 6: 187-98. PMID 7612798 DOI: 10.1007/Bf00051790 |
0.337 |
|
| 1994 |
Ettinger LJ, Gaynon PS, Krailo MD, Ru N, Baum ES, Siegel SE, Hammond GD. A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group. Cancer. 73: 1297-301. PMID 8313334 DOI: 10.1002/1097-0142(19940215)73:4<1297::Aid-Cncr2820730427>3.0.Co;2-# |
0.447 |
|
| 1993 |
Krailo MD, Bernstein L, Sullivan-Halley J, Hammond GD. Patterns of enrollment on cooperative group studies. An analysis of trends from the Los Angeles County Cancer Surveillance Program. Cancer. 71: 3325-30. PMID 8490876 DOI: 10.1002/1097-0142(19930515)71:10+<3325::Aid-Cncr2820711731>3.0.Co;2-K |
0.45 |
|
| 1993 |
Bernstein L, Sullivan-Halley J, Krailo MD, Hammond GD. Trends in patterns of treatment of childhood cancer in Los Angeles County. Cancer. 71: 3222-8. PMID 8490858 DOI: 10.1002/1097-0142(19930515)71:10+<3222::Aid-Cncr2820711712>3.0.Co;2-V |
0.445 |
|
| 1993 |
Feusner JH, Krailo MD, Haas JE, Campbell JR, Lloyd DA, Ablin AR. Treatment of pulmonary metastases of initial Stage I hepatoblastoma in childhood: Report from the Childrens Cancer Group Cancer. 71: 859-864. PMID 8381705 DOI: 10.1002/1097-0142(19930201)71:3<859::Aid-Cncr2820710333>3.0.Co;2-T |
0.45 |
|
| 1993 |
Ettinger LJ, Krailo MD, Gaynon PS, Hammond GD. A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group. Cancer. 72: 917-922. PMID 8334645 DOI: 10.1002/1097-0142(19930801)72:3<917::Aid-Cncr2820720342>3.0.Co;2-Q |
0.43 |
|
| 1992 |
Feig SA, Krailo MD, Harris RE, Baum E, Holcenberg JS, Kaizer H, Steinherz L, Pendergrass TW, Saunders EF, Warkentin PL, Bleyer WA, Hammond GD. Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group. Medical and Pediatric Oncology. 20: 124-129. PMID 1734217 DOI: 10.1002/Mpo.2950200207 |
0.427 |
|
| 1992 |
Finklestein JZ, Krailo MD, Lenarsky C, Ladisch S, Blair GK, Reynolds CP, Sitarz AL, Hammond GD. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. Medical and Pediatric Oncology. 20: 307-11. PMID 1608352 DOI: 10.1002/Mpo.2950200407 |
0.472 |
|
| 1992 |
LaQuaglia MP, Stolar CJ, Krailo M, Exelby P, Siegel S, Meadows A, Hammond D. The role of surgery in abdominal non-Hodgkin's lymphoma: experience from the Childrens Cancer Study Group. Journal of Pediatric Surgery. 27: 230-5. PMID 1564623 DOI: 10.1016/0022-3468(92)90318-2 |
0.422 |
|
| 1992 |
Wiener ES, McGuire P, Stolar CJ, Rich RH, Albo VC, Ablin AR, Betcher DL, Sitarz AL, Buckley JD, Krailo MD. The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal. Journal of Pediatric Surgery. 27: 155-63; discussion 1. PMID 1564612 DOI: 10.1016/0022-3468(92)90304-P |
0.321 |
|
| 1992 |
Miser JS, Smithson WA, Krivit W, Hughes CH, Davis D, Krailo MD, Hammond GD. Phase II trial of indicine N-oxide in relapsed acute leukemia of childhood. A report from the Childrens Cancer Study Group. American Journal of Clinical Oncology. 15: 135-40. PMID 1553901 DOI: 10.1097/00000421-199204000-00008 |
0.447 |
|
| 1992 |
Miser JS, Roloff J, Blatt J, Reaman GH, Krailo MD, Hammond GD. Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute lymphoblastic leukemia: A randomized Phase II trial from the Childrens Cancer Study Group American Journal of Clinical Oncology. 15: 490-493. PMID 1449110 DOI: 10.1097/00000421-199212000-00005 |
0.47 |
|
| 1991 |
Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, Kern W, Sakamoto J, Krailo M, Groshen S. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. The Journal of Urology. 145: 459-64; discussion 4. PMID 1997689 DOI: 10.1016/S0022-5347(17)38368-4 |
0.387 |
|
| 1991 |
Miser JS, Smithson WA, Krivit W, Hughes C, Davis D, Krailo M, Hammond D. Phase II trial of indicine N-oxide in relapsed pediatric solid tumors. A report from the Childrens Cancer Study Group. Investigational New Drugs. 9: 339-342. PMID 1804809 DOI: 10.1007/Bf00183576 |
0.463 |
|
| 1991 |
Ortega JA, Krailo MD, Haas JE, King DR, Ablin AR, Quinn JJ, Feusner J, Campbell JR, Lloyd DA, Cherlow J. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 9: 2167-76. PMID 1720452 DOI: 10.1200/Jco.1991.9.12.2167 |
0.422 |
|
| 1991 |
Ablin AR, Krailo MD, Ramsay NK, Malogolowkin MH, Isaacs H, Raney RB, Adkins J, Hays DM, Benjamin DR, Grosfeld JL. Results of treatment of malignant germ cell tumors in 93 children: a report from the Childrens Cancer Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 9: 1782-92. PMID 1717667 DOI: 10.1200/Jco.1991.9.10.1782 |
0.476 |
|
| 1991 |
King DR, Ortega J, Campbell J, Haas J, Ablin A, Lloyd D, Newman K, Quinn J, Krailo M, Feusner J. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. Journal of Pediatric Surgery. 26: 1074-80; discussion . PMID 1658289 DOI: 10.1016/0022-3468(91)90677-L |
0.473 |
|
| 1991 |
Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M, Levine A. Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial The American Journal of Medicine. 90: 427-433. DOI: 10.1016/0002-9343(91)80081-V |
0.454 |
|
| 1990 |
Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 8: 356-64. PMID 2299375 DOI: 10.1200/Jco.1990.8.2.356 |
0.309 |
|
| 1990 |
Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD. Carboplatin in childhood brain tumors: A children's cancer study group phase II trial Cancer. 66: 2465-2469. PMID 2249186 DOI: 10.1002/1097-0142(19901215)66:12<2465::Aid-Cncr2820661204>3.0.Co;2-N |
0.497 |
|
| 1990 |
Ettinger LJ, Ru N, Krailo MD, Ruccione KS, Krivit WA, Hammond GD. A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group. The American Journal of Pediatric Hematology/Oncology. 12: 301-5. PMID 2240475 DOI: 10.1097/00043426-199023000-00009 |
0.495 |
|
| 1990 |
Ettinger LJ, Ru N, Krailo M, Ruccione KS, Krivit W, Hammond GD. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group. Journal of Neuro-Oncology. 9: 69-76. PMID 2213117 DOI: 10.1007/Bf00167071 |
0.486 |
|
| 1990 |
Fryer CJ, Hutchinson RJ, Krailo M, Collins RD, Constine LS, Hays DM, Heller RM, Davis PC, Nachman J, O'Brien RT. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 8: 1971-80. PMID 1700080 DOI: 10.1200/Jco.1990.8.12.1971 |
0.474 |
|
| 1989 |
Haas JE, Muczynski KA, Krailo M, Ablin A, Land V, Vietti TJ, Hammond GD. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer. 64: 1082-1095. PMID 2547506 DOI: 10.1002/1097-0142(19890901)64:5<1082::Aid-Cncr2820640520>3.0.Co;2-G |
0.397 |
|
| 1989 |
Gill PS, Akil B, Colletti P, Rarick M, Loureiro C, Bernstein-Singer M, Krailo M, Levine AM. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. The American Journal of Medicine. 87: 57-61. PMID 2472743 DOI: 10.1016/S0002-9343(89)80483-8 |
0.336 |
|
| 1988 |
Makley JT, Krailo M, Ertel IJ, Fryer CJH, Baum ES, Weetman RM, Yunis EJ, Bleyer WA, Hammond GD. The relationship of various aspects of surgical management tooutcome in childhood nonmetastatic osteosarcoma: A report from the childrens cancer study group* Journal of Pediatric Surgery. 23: 146-151. PMID 3422682 DOI: 10.1016/S0022-3468(88)80146-5 |
0.393 |
|
| 1988 |
Movassaghi N, Krivit WA, Krailo MD, Hammond GD. Phase I/II study of bisantrene in childhood cancer: a report from the Childrens Cancer Study Group. Medical and Pediatric Oncology. 16: 333-336. PMID 3054454 DOI: 10.1002/Mpo.2950160508 |
0.471 |
|
| 1987 |
Sposto R, Krailo MD. Use of unequal allocation in survival trials. Statistics in Medicine. 6: 119-125. PMID 3589241 DOI: 10.1002/Sim.4780060204 |
0.326 |
|
| 1987 |
Krailo M, Ertel I, Makley J, Fryer CJH, Baum E, Weetman R, Yunis E, Barnes L, Bleyer WA, Hammond GD. A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group. Medical and Pediatric Oncology. 15: 69-77. PMID 3295501 DOI: 10.1002/Mpo.2950150205 |
0.511 |
|
| 1987 |
Gill PS, Levine AM, Krailo M, Rarick MU, Loureiro C, Deyton L, Meyer P, Rasheed S. AIDS-related malignant lymphoma: results of prospective treatment trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 5: 1322-8. PMID 2442321 DOI: 10.1200/Jco.1987.5.9.1322 |
0.427 |
|
| 1986 |
Grunberg SM, Akerley WL, Krailo MD, Johnson KB, Baker CR, Cariffe PA. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis. Cancer Investigation. 4: 379-85. PMID 3801953 DOI: 10.3109/07357908609017518 |
0.384 |
|
| 1986 |
Levine AM, Gill PS, Cohen J, Hawkins JG, Formenti SC, Aguilar S, Meyer PR, Krailo M, Parker J, Rasheed S. Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results. Annals of Internal Medicine. 105: 32-7. PMID 2424353 DOI: 10.7326/0003-4819-105-1-32 |
0.343 |
|
| 1984 |
Grunberg SM, Gala KV, Lampenfeld M, Jamin D, Johnson K, Cariffe P, Strych D, Krailo M. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. Journal of Clinical Oncology. 2: 782-787. PMID 6539812 DOI: 10.1200/Jco.1984.2.7.782 |
0.343 |
|
| Show low-probability matches. |